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Abstract 
The efficient differentiation of retinal cells from human pluripotent stem 
cells remains a major challenge for the development of successful and cost-effective 
cellular therapies for various forms of blindness. Current differentiation strategies 
rely upon exposing pluripotent stem cells to soluble growth factors which play key 
roles during early development (such as DKK-1, Noggin and IGF-1) at 20% oxygen 
(O2). This O2 tension is however, considerably higher than O2 levels during 
organogenesis and may impair the differentiation process. In this study, we examined 
the effect of mimicking the physiological O2 tension (2%) on the generation of 
retinal progenitor cells (RPCs) from human induced pluripotent stem cells (iPSCs) 
and human embryonic stem cells (hESCs). Both cell types were induced to 
differentiate into RPCs at 20% and 2% O2. After three days in suspension culture as 
embryoid bodies (EBs), 2% O2 caused the activation of hypoxia inducible factor 
(HIF) responsive genes VEGF and LDHA and was accompanied by elevated 
expression levels of the early eye field genes Six3 and Lhx2. 21 days after plating 
EBs in an adherent culture, we observed more RPCs co-expressing Pax6 and Chx10 
at 2% O2. qPCR analysis confirmed that lowering O2 tension had caused a rise in the 
expression of both genes compared to 20% O₂. Our results indicate that mimicking 
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physiological O2 is a favorable condition for the efficient generation of RPCs from 
both hiPSCs and hESCs. 
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1. Introduction 
1.1 Photoreceptor dystrophies and possible treatment 
1.1.1 Photoreceptor dystrophies 
Photoreceptors are light-sensing retinal neurons found in the outer nuclear 
layer (ONL) of the retina. Two types of photoreceptors, cones and rods, are 
responsible for vision in the bright and dim lights respectively (Deflyer et al., 2004, 
Pacione et al., 2003). These specialized neurons carry out phototransduction which 
converts light into electrical signals in the first step of the visual cycle (Bowmaker 
and Dartnall, 1980). Dystrophies in photoreceptors result visual impairments and 
possible blindness in the most severe cases. 
Photoreceptor dystrophies are hereditary conditions and characterized by the 
degeneration of photoreceptors due to genetic defects (Table 1.1). Amongst different 
types of diseases, retinitis pigmentosa (RP) is the leading cause of photoreceptor 
degeneration, affecting 1 in every 4000 worldwide (Bundey and Crew 1984). RP is 
characterized by a progressive degeneration of rod and cone photoreceptors over a 
period of life time, leaving severely attenuated ONL of the retina where rod and cone 
photoreceptors normally reside (Hartong et al., 2006). Typical patients with RP 
experience night vision loss early in their life time (around adolescence) that is 
followed by the loss of side and central vision as the disease advances (around age 60, 
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Hartong et al, 2006).  
To date, mutations in more than 45 genes have been identified that cause 
degeneration of photoreceptors. The mutated genes are exclusively found in rod 
photoreceptors and are the cause their death (Haung et al., 1995). For instance, 4-5% 
of RP are caused by mutations in α and β subunits of cGMP phosphodiesterase 6 
(PDE6A and PDE6B), genes that regulate rod cGMP levels (McLaughlin et al., 
1985). When rods are not stimulated by light, a high concentration of cGMP opens 
cation channels until the release of the neurotransmitter glutamate (Cobbs and Pugh, 
1985). Mutations in PDE6A and PDE6B however, cause an abnormal increase in 
cGMP concentrations in rod outer segment. This prolongs the opening of cGMP-
gated cation channels and an excessive flow of cations into the cells from the plasma 
membrane results in the death of rod photoreceptors by mostly unknown routes 
(Yamashita and Field 1972).  
It has also been reported that the presence of mutated rods themselves is 
detrimental to surrounding healthy rod photoreceptors. This can be attributed to 
metabolism and structural interferences and the formation of intracellular protein 
aggregates (Illing et al., 2002). It is still unknown the cause of cone photoreceptor 
death when mutations in genes are exclusively found in rod photoreceptors. This 
highlights the underlying cone photoreceptors’ reliance on rod for their survival 
16 
 
which requires further investigation on the interaction between rod and cone 
photoreceptors for a better understanding of the disease (Leveillard et al., 2004).  
 
 
Table 1.1 The list of hereditary photoreceptor dystrophies. RP in particular, is a common cause of 
blindness, affecting 1 in 4,000 people in the world. There is currently no effective treatment available 
for the above disorders. 
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1.1.2 Potential treatments for retinal dystrophies 
1.1.2.1 Gene therapy 
 Gene therapy is a therapeutic strategy whereby a normal gene is introduced 
into the cells to compensate a defective gene that causes diseases. Clinical trials for 
gene therapy began 20 years ago and encouraging results have been emerging for 
various genetic diseases in the last 3-10 years (Bainbridge et al., 2008; Cartier et al., 
2009; Ponder, 2011). In 2009, a study published in The New England Journal of 
Medicine reported the outcome of a phase I human clinical trial of gene therapy for 
one type of hereditary photoreceptor dystrophies Leber’s congenital amaurosis 
(LCA) (Cideciyan et al., 2009). Patients suffering from the disorder have a mutation 
in RPE65 gene which affects photoreceptors viability and functionality (Hauswirth et 
al., 2008). In this trial, normal RPE65 gene was delivered into the participants’ retina 
where remaining photoreceptors resided via a recombinant adeno-associated viral 
(rAAV2) vector. The sensitivity to the dim light increased a few weeks after the 
treatment and significant visual improvements were sustained up to a year post 
therapy without any signs of side effects. This human hereditary retinal disorder was 
the first of its kind to show visual improvement after treatment. The participants are 
required to be monitored for a full three years for a phase I clinical trials and for 
another 15 years for health impacts as is required by the FDA for any gene therapy 
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trials. 
 It has been reported that neutrophic factors are a possible candidate for 
therapeutic agent for treating RP (Faktorovich et al., 1990). In particular, ciliary 
neutrophic factor (CNTF) has been reported to prevent photoreceptor degeneration in 
animal models of RP (Cayouette and Gravel, 1997; LaVail et al., 1998). Neurotech 
utilized an encapsulation technology where retinal pigmented epithelium (RPE) cells 
that were transfected with CNTF were encapsulated with a semipermeable 
membrane. This allows diffusion of CNTF proteins to the host retina whilst giving 
protection from the host immune system. Phase I clinical trial reported that this 
delivery system was reported to be safe and effective in improving vision after 
transplanting into human eye (Sieving et al., 2006). 
 
1.1.2.2 Cell therapy 
 The term cell replacement therapy refers to a therapeutic concept that 
transplants functional cells into organs to replenish damaged or deteriorated 
counterparts to restore or rescue their functionality. Cell therapy is an attractive 
candidate for developing treatments for photoreceptor dystrophies as intraocular 
spaces are known to be immunoprivileged sites (Streilein et al., 2002). In order to 
develop a successful therapy for photoreceptor dystrophies, transplanted retinal cells 
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have to survive in the host retina environment and integrate in the ONL of the host 
retina to form functional synaptic connections for transmission (Yang et al., 2010). 
Below is a summary of human clinical trial of retinal transplantation for patients 
suffering from RP. 
 
Table 1.2 
 
Table 1.2. A summery of up to date human clinical trials for photoreceptor transplantation for patients 
suffering from RP. ERG (electroretinography) measures electrical responses of various retinal cells 
(including photoreceptors) in response to light stimuliation. It is a commonly used diagnosis for 
various retinal diseases. 
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1.1.2.3 Challenges associated with retinal cell therapy for 
photoreceptor dystrophies 
Almost two decades of human retinal transplantation has not yet achieved 
satisfactory long term visual improvement in patients with RP. This can be 
accountable for the lack of the donor cells’ ability to integrate into the damaged 
retina to form functional photoreceptors. Early retinal transplantation studies in 
animals revealed that integration of donor retinal cells with the host retina for 
functional recovery has proven much more challenging than ensuring their survival 
after transplantation. It is often revealed that transplanted retinal cells tend to form 
rosettes of photoreceptors rather than well-organized layers with the host retina 
(Gouras and Algvere, 1996; Juliusson et al., 1993). It was later revealed that any 
functional improvements observed with the transplantation was due to the paracrine 
effect of survived retinal cells after transplantation (Gamm et al., 2007). 
Transplanting sheets of photoreceptors has shown to minimize the formation of 
rosettes in the host retina but this is technically more demanding (Seiler and Aramant, 
1998; Silverman et al., 1992).  
A breakthrough was made in 2006 when Maclaren et al identified the exact 
type of transplantable retinal cells that survives and integrate into the host retina of 
blind mice (MacLaren et al., 2006). By examining cells at different developmental 
stages (ranged from embryonic day (E)11.5 to adult mice), it was observed that only 
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post-mitotic immature rod precursor cells (postnatal 1 to 7 days) expressing neural 
retina leucine zipper (Nrl) transcription factor survived and integrated well into adult 
or degenerating retina to develop into mature and functional photoreceptors. 
Transplantation of Nrl-positive cells into the rhodopsin knockout mouse 
demonstrated improved sensitivity to dim light measured by ganglion cell layer 
activity compared to the eye that received the sham injection. In addition, the pupil 
of the eyes that received Nrl-positive cells reacted better to dim light compared to the 
sham injection group.  
In an independent study, researchers have demonstrated that cone precursor 
cells expressing Crx can also integrate into host retina and form mature rods and 
cones in animal models of LCA (Lakowski et al., 2010). Crx+ cells were isolated 
using FACs from CrxGFP transgenic mice from various developmental stages (E12.5, 
E13.5, E14.5, E15.5, E16.5, E17.5, P1 and P3). It was revealed that upon 
transplantation, Crx+ cells migrated to and integrated in the ONL of the retina to and 
further developed into mature photoreceptors (except for Crx+ from E12.5). It was 
also observed that the integration efficiency was dependent on the stage at which 
Crx+ cells were isolated as post-natal cells showed the greatest integrated cells (up to 
15,000 cells compared to a few thousands by embryonic Crx+ cells). 
The findings provide a platform to develop an efficient and effective retinal 
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cell therapy. Failure to sustain long term visual improvements after retinal cell 
transplantation could be attributed to the heterogeneity nature of the donor cells. 
Identifying transplantable donor cells as shown by Maclaren et al and Lakowski et al, 
however would allow isolation and purification of these cells which could enhance 
efficacy of transplantation. 
It would be exciting to observe whether transplantation of Nrl+ and Crx+ 
cells in patients with genetic photoreceptor dystrophies could sustain long term 
visual improvements (Figure 1.1). To generate Nrl+ and Crx+ cells that are suitable 
for human clinical application, a novel strategy has to be developed that avoids 
creating transgenic organisms for obvious ethical reasons. It is widely believed that 
Nrl+ and Crx+ cells could be generated from pluripotent stem cells, unspecialized 
cells with a potential to become almost any types of cells in the body. (Fig 1.1). 
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Figure 1.1 
 
Figure 1.1. Current and future retinal transplantation strategies. (A) Maclaren et al., 
demonstrated the isolation of Nrl+ rod precursors from postnatal mouse that formed new 
photoreceptors and improve vision after transplantation into the blind mouse model. (B) Possible 
human retinal transplantation strategy using cells derived from human stem cells instead of aborted 
fetus. 
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1.2. Types of human Stem Cells 
1.2.1. Human Embryonic stem cells (hESCs) 
1.2.1.1. hESCs culture 
hESCs are a unique population of cells in that they self-renew themselves 
without adopting specific functions. Due to their uncommitted nature, they are 
thought to be pluripotent, capable of becoming almost all types of cells in the body 
(Evans and Kaufman, 1981). The first hESCs line was established in 1998 by the 
Thomson group from Wisconsin University (Thomson et al., 1998). hESCs are 
created  from the surplus in vitro fertilized embryos originally created as part of in 
vitro fertilization (IVF) treatment. These embryos are donated for research purposes 
by parental donors under informed consent. 
The inner cell mass (ICM) are isolated from the blastocyst and cultured in 
the presence of mouse embryo fibroblasts (MEFs) with supplement of bFGF to 
maintain pluripotency (Thomson et al., 1998). MEFs are regarded as “feeder cells” as 
they provide nutrients and unknown growth factors that are thought to support 
pluripotency in the culture. This is the classic maintenance culture condition although 
hESCs can also be maintained in the presence of human embryo fibroblasts (hEFs) or 
in the “feeder-free” conditions using commercially available matrices (Hernandez et 
al., 2010). These culture methods eliminate the possibility of cross-contamination 
between the two species which are crucial for hESCS clinical applications. During in 
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vitro culture of hESCs, it is a frequent laboratory practice to examine whether hESCs 
exhibit all the fundamental properties of true hESCs. This process is often known as 
characterization and commonly used methods to characterize typical properties of 
hESCs are summarized below in Table 1.3.  
 
Table 1.3 
 
Table 1.3 Characterization of hESCs. hESCs are often characterized during in vitro culture using a 
various laboratory techniques. * Due to ethical reasons, chimera experiments with mammalian ESCs 
are not permitted. 
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1.2.1.2 hESCs differentiation 
Since the establishment of the first hESCs lines in 1998, intense research 
interests have been focused on generating specific cell types that are functional and 
capable of restoring damaged counterparts in vivo after transplantation. Pluripotent 
hESCs can be coaxed to become specific types of cells. The process in which 
uncommitted cells adopt specific characteristics or functionality is termed 
“differentiation”. Enrichment of certain types of cells by differentiation is critical as 
transplantation of pluripotent stem cells cause tertatoma in vivo (Fukuda et al., 2006; 
Choo et al, 2009). Traditionally, differentiation of hESCc involves the formation of 
embryoid bodies (EBs) in suspension that triggers differentiation of pluriopotent 
stem cells into three germ layers (Thomson et al., 1998). These aggregates of cells 
are then plated in the presence of growth factors and small molecules to direct 
differentiation into a specific lineage of cells. The addition of growth factors in the 
differentiating cultures mimics the signaling pathways during the development of the 
corresponding types of cells.  
For instance, it was reported that the generation of pancreatic β-cells 
(endoderm lineage cells) is possible from spontaneously differentiating EBs but only 
1-3% of the cells were insulin-expressing cells (Assady et al., 2001). This is however 
significantly increased when EBs were cultured adherently in the presence of insulin-
transferrin-selenium-ﬁbronectin medium, followed by supplementation with N2, B27, 
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and bFGF. 11 days post plating EBs in the growth factors revealed up to 70% insulin-
expressing cells in the culture (Segev et al., 2004).  
Many mesodermal lineage cells are possible candidates for various 
degenerative diseases. For instance, blood forming hematopoietic cells can be 
generated from hESCs which can then subsequently be used to treat patients with 
leukemia (Ledran et al., 2008). This differentiation has been achieved by 
supplementing interleukin 3 and interleukin 6, in combination with BMP4 after EB 
formation (Chadwick et al., 2003). In addition, it has been reported that 
cardiomyocytes, which could be used to treat cardiac diseases such as myocardial 
infarction, can be generated from hESCs using activin-A and bone morphogenic 
protein 4 (BMP4, Laflamme et al., 2007). Bone and cartilage cells, potential 
therapeutic agents for osteoporosis and osteoarthritis, are differentiated using small 
molecules such as ascorbic acid, β-glycerophosphate and dexamethasone (Sottile et 
al., 2003).  
Generating functional neurons for cell therapy is a subject of intense 
investigation. The first evidence of neural differentiation was demonstrated in 2001 
when neural progenitor cells (NPC) were generated and expanded in the presence of 
B27, epidermal growth factor (EGF) and basic fibroblast growth factors (bFGF, 
Reubinoff et al., 2001). Retinoic acid (RA) is a commonly used small molecule for 
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induction of various neurons. hESCs-NPCs were also capable of differentiating into 
dopaminergic neurons in the presence of RA, FGF8 and sonic hedgehog (SHH) 
(Perrier et al., 2004) and oligodendrocyte in the presence of bFGF and EGF which 
are currently in Phase I human clinical trial for the safety of the cells for spinal cord 
injuries (Nistor et al., 2005). Specific populations of cells from hESCs can also be 
achieved through co-culture systems with tissues derived from other species or 
through genetic manipulation. These methods are efficient in generating specific 
cells from hESCs but they have been regarded as not suitable for therapeutic 
purposes due to safety issues concerning with viral vectors and cross contamination 
(Li et al., 2008). 
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1.2.1.3 Issues associated with hESCs 
In 2009, a ground-breaking milestone was achieved when Geron announced 
the first ever human clinical trial approval for hESCs-based therapy for treating 
spinal cord injuries (Table 1.4). This was followed by Advanced Cell Technology 
(ACT) who began their human clinical trial for the treatment of age-related macular 
degeneration (AMD) using retinal pigment epithelium derived from hESCs (Table 
1.3). Despite promising advances, hESCs-based cell therapy faces major challenges 
that are still to be overcome to become successful and viable treatment.  
It is well documented that allerogenic transplantation of hESCs-derived cells 
raises concerns with immunogenicity (Drukker and Benvenisty, 2004). This can be 
avoided, to some extent, by administrating systemic immunosuppressive drugs but 
this could leave patients to venerable to opportunistic infections (Choumerianou et 
al., 2008). It has been reported that engraftment of hESCs-derived cells is not 
required to exert therapeutic effects. In this study, hESCs-derived endothelial cells 
(hESCs-ECs) were encapsulated with Matrigel and implanted into a mouse model of 
hindlimb ischemia. The implantation of encapsulated hESCs-ECs was not engrafted 
in the host tissue but showed functional improvements (measured by blood flow in 
the ischemic region) through a paracrine effect of secreted angiogenesis-related 
factors (Moon et al., 2011(b)). Other strategies to overcome immunogenicity of 
hESCs include creating patient-specific hESCs through somatic nuclear transfer 
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(Wilmut et al.,1997) and creating induced pluripotent stem cells (iPSCs, which are 
explained in depth in the following chapter). 
Regardless of hESCs differentiation protocols, all hESCs differentiation 
cultures are always heterogeneous. Among the presence of different types of cells, 
residual pluripotent hESCs or proliferating progenitor cells cause tumour formation 
after transplantation. For this reason, it is a prerequisite to remove tumorigenic cells 
in the cultures prior to transplantation for safe treatment. The most common 
technique to create cultures free of tumorigenic cells is using fluorescence activated 
cell sorting (FACS). This can be achieved through either isolating tumorigenic cells 
(negative sorting) or specific cell populations (positive sorting) based on the 
expression of cell surface markers. For instance, isolating Sox1-positive cells and 
subsequent transplantation into the striatum did not form teratoma 8 weeks post 
transplantation (Fukuda et al., 2006). For cell types that do not have known cell 
surface markers specific for them, the negative sorting is a preferred method (Choo 
et al., 2008). Other methods include the use of pharmacological agents that target the 
dividing cells. For instance, N-oleoyl serinol specifically induces apoptosis of 
pluripotent stem cells in the differentiation culture (Bieberich et al., 2004).  
Along with safety issues associated with hESCs-based therapy, ability to 
generate a large number of functional cell types from hESCs remains one major 
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hurdle for efficient and economical therapy. hESC differentiation strategies 
mentioned in the previous section are designed based on the studies of the 
developmental event of tissues during the early human development. Mimicking 
these microenvironment during hESC in vitro differentiation however, has not been 
proven to be effective as many aspects of developmental studies remain unknown 
due to a sheer complexity of organogenesis. This often results in lengthy hESCs 
differentiation protocols generating a low number of desired cell types. For instance, 
it has been reported that hESCs can be directed to differentiate into cells with 
pancreatic phenotypes but only a small percentage of those cells meet the criteria for 
functional pancreatic beta cells (Naujok et al., 2011). It has been reported that a large 
number of functional neuronal cell types could be produced using a combination of 
feeder cells, growth factors and genetic manipulation (Li et al.,2008). However, the 
use of animal derived cells and gene modification are not suitable for human clinical 
applications (Choumerianou et al., 2008). Therefore developing efficient yet 
clinically acceptable differentiation protocol remains a monumental challenge for a 
therapy that is efficient and cost-effective. 
Other issues related to hESCs-based therapy include the lack of engraftment 
of hESCs-derived cells after transplantation for functional recovery, ethical issues 
relating the destruction of embryo for derivation of hESCs lines and possible cross 
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contamination from animal derived medium components (Correia et al., 2005, Lo 
and Parham, 2009).  
 
Table 1.4 
 
Table 1.4. Clinical application of hESCs-based cell therapy for degenerative conditions. 
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1.2.2. Human induced pluripotent stem cells (iPSCs) 
1.2.2.1 iPSCs technologies 
 iPSCs are ESCs-like pluripotent stem cells that are derived by transfection of 
a combination of genes in somatic cells (Takahashi et al., 2007; Yu et al., 2007). 
iPSCs are cultured in the same way as hESCs and exhibit many characteristics of 
hESCs such as the expression of stem cell markers, proliferative capacity, teratoma 
formation and the ability to differentiate into the three embryonic germ layers (see 
section 1.1). Despite reported similarities between the two cell types, a full extent of 
analysis is still required to determine whether it can be a direct substitute for ESCs.  
 The first human iPSCs lines were created by two independent groups in 
2007 (Takahashi et al., 2007; Yu et al., 2007). Both groups demonstrated 
reprogramming of human somatic cells by delivering a combination of four 
transcription factors (Yamanaka factors: Oct4, Sox2, Klf4 and c-Myc and Thomson 
factors: Oct4, Sox2, Nanog and Lin28) required for pluripotency using retroviral 
vectors. This method however has become less popular due to concerns over 
potentially activating cancer-causing genes (oncogenes) introduced in the host 
genome by the viral vectors. In order to avoid the complications of potential cancer 
formation, other researchers have used alternate gene delivery systems. Stadtfeld et 
al used an adenovirus to introduce a combination of genes to reprogramme mouse 
skin cells into iPSCs (Stadtfeld et al., 2008). The significant advantage of using 
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adenovirus is that it does not integrate any of their own genes into the host genome, 
minimizing the risk of causing mutation of the host genome. Despite ensuring safety 
of iPSCs, their creation using this technique compromises efficiency as its yield is 
100-fold lower than the one describe in Yamanaka and Yu studies. 
Following from their initial study of reprogramming using retroviral vector, 
Yamanaka et al demonstrated another ground-breaking iPSCs technology by which 
mouse skin cells were reprogrammed into iPSCs without using a vector (Okita et al., 
2008). In this study, cells were transfected with two plasmids, one carrying c-Myc 
and the other carrying the rest of the factors Oct4, Sox2 and Klf4. Although this 
method avoids using viral vectors, this technology still uses cancer-causing gene c-
Myc and suffers from a low efficiency.  
The technique which generates clinically more friendly iPSCs at reasonable 
efficiency has been described using transposon-based vectors. Using such vectors, 
integrated genes can be removed after completion of reprogramming, leaving the 
host genome unaltered and free of oncogenes (Kaji et al., 2009). Using piggyBac 
transposons, researchers constructed a vector with a single expression cassette 
containing the four reprogramming factors. The vector was then introduced into 
mouse embryonic fibroblasts with transponase which yielded iPSCs with a 
comparable efficiency to integrating vectors (Yusa et al., 2009). By sequencing the 
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integration site of piggyBac vector, it was revealed that the vector was successfully 
excised from the host genome. In addition, they further accessed pluripotency of 
resulting iPSCs by teratoma and chimera experiment.  
In 2009, Ding et al developed a novel iPSCs technology that relies on the 
delivery of proteins to the somatic cells instead of transcription factors (Zhou et al., 
2009). In this study, authors postulate that delivering reprogramming proteins 
directly to somatic cells avoids potential tumourgenesis. In order for proteins to pass 
through the cell membrane, the four reprogramming factors were tagged with a poly-
arginine protein transduction domain and expressed in inclusion body of E.coli 
which were solublized, refolded and purified. This iPSCs technology has major 
advantages over previous ones that involve delivering transcription factors. The most 
significant advantage is that protein delivery eliminates the risk of developing cancer 
as it does not modify the host genome. 
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Figure 1.2 
 
Figure 1.2. Current iPSCs technologies. 
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1.2.2.2 Application of iPSCs  
 Production of iPSCs has raised the hope for personalized cell replacement 
therapy. In theory, such a practice would involve isolating skin cells from a patient, 
reprogram into iPSCs, then differentiate into a certain cell type before putting back 
into the patients. In addition, such transplantation is autologous, circumventing the 
need to accompany immunorepressive drugs with the treatment (Amabile and 
Meissner, 2009). This concept has been demonstrated when researchers created 
iPSCs from a patient suffering from a neurodegenerative condition named 
amyotrophic lateral sclerosis (ALS) which were then differentiated into motor 
neurons that are destroyed by the disease (Mine-Neto et al., 2011). This potential 
clinical application of iPSCs is considered as a long term application which requires 
more fundamental investigation and validation. More immediately, iPSCs could 
provide an important tool for producing a test bed for toxicology test for drug 
development and modeling human diseases to understand underlying mechanisms 
(Heng et al., 2009; Yokoo et al., 2009). 
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Figure 1.3 
 
Figure 1.3. Conceptual iPSCs-based cell therapy. (A) Somatic cells are isolated from the patient. 
(B) Somatic cells are reprogrammed into iPSCs using above-mentioned technology. (B) Subsequent 
iPSCs are induced to differentiate into functional specialized cells. (B) iPSCs-derived cells are 
transplanted back into the patient. 
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1.2.2.3 Challenges for iPSCs  
 As far as therapeutic application of iPSCs is concerned, the first hurdle that 
needs to be overcome is developing technologies that robustly produce safe iPSCs. 
Reprogramming cells using viral vectors is potentially tumorigenic due to the 
presence of the integrated oncogenes in the host genome. Technologies for creating 
safer iPSCs have been developed using piggyBac transposons or protein delivery 
systems but their efficiency still remains to be optimized as currently yield is around 
the region of 0.1-1% (Yamanaka et al., 2007, Zhou et al., 2009).  
iPSCs therapy would have advantages over hESCs in that they are ethical 
and patient-specific which eliminates the risk of immune rejection. Despite iPSCs 
sharing many similar characteristics with hESCs, these two cells lines are 
fundamentally two different types of cells. Studies have shown differential 
expression level of many genes between the two cell types and noticeable differences 
in epigenetic methylation also have been observed (Lister et al., 2011). However, it 
has also been reported that variation in the gene expression profiles between hESCs 
and iPSCs is no more than the variability observed between individual hESC lines 
(Guenther et al., 2010). Whether these differences are consequential in terms of 
functionality and safety concerns, are subject to further investigation (Li et al., 2011). 
Recently, one study has reported that iPSCs can provoke immune rejection upon 
transplantation, suggesting that more transplantation studies are also required for the 
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safety of possible iPSCs-based therapy (Zhao et al., 2011). 
Despite circumventing problems associated with immunogenicity, 
transplantation of iPSCs-derived cells is still susceptible to tumour formation. It is 
believed that directly reprogramming somatic cells to functional specialized cells 
without the intermediate pluripotent stage reduces the risk of forming teratoma. This 
concept was first described by Vierbuclen et al. In this study, researchers screened 
numerous fate inducing factors and revealed that a combination of Brn2, Ascl1 and 
Myf1l (BAM combination) efficiently generates functional neurons from mouse 
embryonic and postnatal fibroblasts (1.8-7.7%, Vierbuclen et al., 2010). This 
lentiviral vector-mediated transduction generates induced neuronal (iN) cells 
expressing typical pan neuronal markers MAP2, TuJ1 and NeuN. In addition, these 
cells were shown to generate action potentials measured by electrophysiological 
recording. The BAM combination was also capable of generating iN cells from 
human fetal fibroblasts as early as 7 days after transduction (Pang et al., 2011). 
Despite exhibiting neuronal morphologies, these cells were functionally immature. 
This prompted screening of further 20 factors in search for a factor that could 
enhance the generation of iN cells in combination with the BAM. It was revealed that 
NeurD1 with BAM combination generated mature iN cells and that expressed pan 
neuronal markers Tuj1, NeuN and NCAM. In addition, these human iN cells were 
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shown to generate action potentials around 35 days post transduction. In addition to 
directly reprogramming functional neuronal cells from fibroblasts, it has been also 
described that functional cardiomyocytes can be directly reprogrammed from 
postnatal cardiac or dermal fibroblasts (Ieda et al., 2010). Researchers in this study 
used a combination of Gata4, Mef2c and Tbx5 to generated 30% induced 
cardiomyocytes (iCMs) expressing cTnT markers that were also exhibiting 
spontaneous contraction. 
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1.2.3 Adult Stem Cells (ASCs) 
 Adult stem cells (ASCs) reside in tissues in the body and are responsible for 
repairing and replacing damaged cells or tissues of organs throughout the life time 
(Barrilleaux et al., 2006). The list of organs that contain stem cells population 
continues to grow that includes bone marrow, brain and skeletal muscle (Table 1.5). 
ASCs are characterized by their ability to self-renew for the life time of the organism. 
This cannot be analyzed in vivo for complex organisms like human but in vitro 
assays have been shown their proliferative capabilities (Fernando et al., 2010).  
Another property that characterizes ASCs is their ability to differentiate into 
multiple types of specialized cells (Davis and Temple, 1994; Bianco et al., 1999). 
Traditionally, it has been believed that ASCs are multipotent stem cells, giving rise to 
limited types of specialized cell of the tissue in which they reside. For instance, 
hematopoietic stem cells (HSCs) from bone marrow differentiate into all types of 
blood cells to replenish aged blood cells and neural stem cells (NSCs) found in adult 
brain tissues have been shown to produce three types of nerve cells (neuron, 
astrocyte and oligodendrocyte) depending on the signal they received (Gage et al., 
1995). This limited differentiation capacity of ASCs restricts their therapeutic 
application to only certain types of degenerative medical conditions (Kocher et al., 
2001; Shiabuddin et al., 1999). It is not until recently when studies have shown that 
ASCs can generate specialized cell types of other tissues that either generated from 
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the same embryonic germ layer or from a different germ layer (Prockop, 2003). For 
instance, studies have shown that NSCs isolated from adult brain tissue could 
generate hematopoietic cells and reciprocally, bone marrow derived stem cells were 
shown to differentiate into neural tissues (Mezey et al., 2000; Woodbury et al., 2000). 
Their ability to differentiate into specialized cell types of other embryonic germ layer 
often referred as “transdifferentiation” which excites the scientific community for 
their potential wider applications in cell replacement therapy.  
ASCs transplantation is autologous, harvesting ASCs from tissues from 
individuals which are then induced to differentiate into a specific cell type in vitro 
before placing back into them. This type of transplantation has a critical advantage 
over ESCs-based transplantation as this lessens the complication of immune rejection 
and the possibility of developing tumour-like formation, as well as avoiding ethical 
issues associated with ESCs-based therapy (Cultler and Antin, 2001). Despite 
promising evidence of transdifferentiation capacity of ASCs, there are still lingering 
doubts over whether ASCs are capable of generating functional mature cell types of 
other embryonic germ layers. One study demonstrated that born marrow-derived 
stem cells (BMCs) are capable of differentiating into retinal neurons (GFAP, 
calbindin, rhodopsin and vimentin) upon transplantation into the intravitreous space, 
but failed to either integrate with the host retina or further develop into mature 
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photoreceptors (Tomita et al., 2001).  
 
Table 1.5 
 
Table 1.5. Sources for adult stem cells in the body and their functions. 
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1.3. Retinal differentiation of human pluripotent stem cell 
1.3.1. Differentiation strategies 
The retinal differentiation of iPSCs and hESCs is largely based on 
mimicking events taking place during mammalian retinal development by 
supplementing key pathway agonists or antagonists. During early mammalian 
development, antagonism of bone morphogenetic protein (BMP) and Wnt signaling 
pathways reportedly plays significant roles in defining telencephalon of the forebrain 
(Mukhopadhyay et al., 2001). Following the forebrain specification, the formation of 
optical vesicles (OV) is induced from the diencephalon of the forebrain as it 
bilaterally evaginates and expands through mesenchyme towards the surface 
ectoderm (Adler and Canto-Soler, 2007). The contact between the OV and the 
ectoderm triggers complex structural changes as the surface ectoderm thickens and 
becomes a structure called a lens placode, which eventually invaginates the OV and 
forms a two-layered optic cup (OC) and lens vesicle (Fuhrmann et al., 2000). The 
key cellular fate decision of neural retina versus the retinal pigment epithelium 
(RPE) in the developing OC is regulated by the inductive signals emanating from the 
surrounding extraocular tissues (Saha et al., 1992; Chow and Lang, 2001). 
The presumptive retina is initially found on the thick inner wall of the cup, in 
close contact with the surface ectoderm (Dragomirov 1937). Growth factors such as 
fibroblast growth factor (FGF) and sonic hedgehog (Shh) from the surface ectoderm 
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have been reported to induce the differentiation of the OC into retina lineage cells, 
which express neural retina-specific transcription factors Chx10 and Pax6 (Pittack et 
al., 1997). Extraocular mesenchyme, on the other hand, promotes the differentiation 
of the presumptive RPE on the thin outer layer of the OC, possibly under the 
influence of activin-like signals (Fuhrmann et al., 2000; Kagiyama et al., 2005). The 
pigmented cells express RPE specific marker Mitf and was shown to inhibit the 
expression of Chx10 and Pax6 (Fuhrmann et al., 2000). The cells found in the OC 
are generally regarded as retinal progenitor cells (RPCs) and have the ability to 
differentiate into the retinal neurons in a sequential manner by producing  ganglion 
cells, cone photoreceptors and horizontal cells first, followed by amacrine cells and 
rod photoreceptors and lastly bipolar and Muller glia (Altshuler et al., 1991). 
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Figure 1.4 
 
Figure 1.4. Schematics of key development features during mammalian retina development. (A) 
The formation of optic vesicle from the diencephalon. (B) Specification of the optic vesicle into 
presumptive RPE, neural retinal (NR) and optic stalk (OS) upon contact with the surface ectoderm,. 
(C) The formation of optic cup and lens vesicle. (D and E) Transition from early to mature optic cup. 
Lens vesicle becomes a solid structure as optic cup matures and RPE and NR becomes opposed. Optic 
stalk becomes optic nerve (Alder and Canto-Soler, 2007).  
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1.3.2. Tomas Reh Group, Wisconsin University, USA  
 A group of researchers from Wisconsin University in 2006 first 
demonstrated the production of hESCs-derived retinal cells and their ability for 
functional recovery in blind mice (Lamba et al., 2006). Lamba et al developed an 
efficient protocol which generates almost 80% of RPCs co-expressing typical RPC 
markers Pax6 and Chx10 from H1 hESCs line. The protocol uses soluble growth 
factors DKK-1 and Noggin to antagonize Wnt and BMP signal pathways 
respectively which mimic the forebrain formation during the early development (See 
section 1.1.1). In addition, they showed that supplementing Insulin-like growth factor 
1 (IGF-1) specifically enhances RPC lineage differentiation in favour of other 
anterior neuronal lineages. H1 hESCs were cultured as EBs for three days in the 
media supplemented with DKK-1, Noggin and IGF-1 as well as N2 and B27 
supplements which are widely used for neural induction. The subsequent EBs were 
plated on poly-d-lysine/matrigel coated dishes with the same media as well as bFGF 
which enhances photoreceptor development (Hicks and courtois, 1992). The adherent 
differentiation of EBs was cultured for 21 days which resulted in ~80% of colonies 
co-expressing Pax6 and Chx10, quantified by immunoreactivity to the markers. It 
was also revealed 21 days after differentiating hESCs yielded cells expressing retinal 
neurons expressing PKCα (bipolar marker), Prox-1 (horizontal cells), Tuj1 (Ganglion 
cells), Neurofilament-M (Amacrine cells). In addition, it was also shown by 
49 
 
immunocytochemistry that immature (Nrl and Crx) and mature (s-opsin and 
rhodopsin) photoreceptor markers were present in the culture although their 
population was very low. In order to examine whether immature photoreceptors 
could differentiate into mature phenotype, they co-cultured hESCs-derived retinal 
cells with retinal explants from adult mice and observed integration and 
differentiation into mature photoreceptors in the explants.  
This retinal differentiation protocol was validated with several iPSCs (iPSC-
MHF2 c1 and c2) and hESCs lines (Hues6, 14 and 16 and Mel1 and 2) (Lamba et al., 
2010). It was revealed that the differentiation protocol was robust as each cell lines 
behaved with a minor variation in the expression level of Crx, although iPSCs-MHF2 
c2 was found to be less effective amongst them all.  
This retinal differentiation of iPSCs and hESCs has been the base for other 
retinal differentiation studies such as that of Amirpour et al ( 2001) and shown to be 
effective in inducing retinal differentiation with mouse iPSCs (Tucker et al., 2011). 
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1.3.3 Takahashi Group, Riken University, Japan 
 The group developed the first differentiation protocol that induces neural 
retinal lineage differentiation from mouse ESCs (mESCs) (Ikeda et al., 2005). The 
authors investigated a wide spectrum of pathway antagonists during EB cultures and 
observed that the combination of DKK-1, Lefty-A (nodal antagonist), Activin-A and 
5% FCS (also known as SFEB/DLFS culture) was effective in inducing retinal 
differentiation yielding 16% of RPCs co-expressing Pax6 and Rx. The percentage of 
cells expressing mature photoreceptor markers was very low (~0.5% of the culture) 
but this was significantly enhanced when co-cultured with embryonic retinal culture 
(~30% of the culture). In 2008, the group developed the first chemically-defined 
culture condition that avoids the use of co-culture system with animal derived tissues 
(Osakada et al., 2008). The SFEB/DLFS culture was optimized to produce RPCs 
from hESCs. EBs were cultured for 20 days without the presence of FCS but in the 
presence of Dkk-1 and Lefty-A. EBs were then plated on poly-D-
lysine/laminin/fibronectin-coated dishes and by day 35, 16% of cells co-expressed 
RPCs markers Rx and Pax. To determine whether RPCs could further differentiate 
into mature photoreceptors, the adherent culture was extended and photoreceptor 
precursors expressing Crx marker was observed on day 90. The percentage of Crx-
positive cells increased to 11.3% on day 120 and 20% on day 130 when RA and 
taurine, chemical that are known to involve in the photoreceptor development, were 
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supplemented in the culture on day 90. In addition, on day 200, the culture also 
contained 8.5% rhodopsin positive cells which co-expressed recoverin. The 
expression of cone markers such as red/green opsin (8.9%) and blue opsin (9.4%) 
was also present at the same time point. This protocol was validated with three iPSCs 
lines (201B6, 201B7 and 253G1) and produced RPCs with a comparable efficiency 
(~20%) but one iPSCs line (210B6) failed to differentiate into RPCs (Hirami et al., 
2009). The other two lines however, further differentiated into Crx-positive cells 
(14%) on day 90. Upon the treatment with RA and taurine at this time point yielded 
13% recoverin and rhodopsin co-expressing cells on day 120. In the following study, 
the group demonstrated that growth factors, which are normally produced in 
animals/E-coli, can be substituted with soluble small molecules (Osakada et al., 
2009). The use of small molecules has a number of advantages over growth factors in 
that they minimize cross-species contamination, small lot-to-lot variation and low 
cost. Chemical inhibitors such CK1-7 and SB-431542 antagonise wnt and nodal 
pathway respectively and induces retinal differentiation with a comparable efficiency 
to Dkk-1 and Lefty-A induced differentiation of iPSCs. This differentiation protocol 
was verified by an independent group who used the same combination of growth 
factors to derived RPCs from hESCs (Nistor et al., 2010). 
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 The group is the first to develop a chemically defined media composition for 
generating mature photoreceptors without the use the co-culture system with animal 
explants. For this reason however, differentiation efficiency has been compromised 
as the protocol takes up to 180 days to generate mature photoreceptors. Future 
studies are required to efficientlty generated photoreceptors in the chemically defined 
media. 
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1.3.4. Transplantation of hESCs- and iPSCs- derived retinal cells in 
animal models 
In order to demonstrate whether hESCs- or iPSCs-derived retinal cells are 
clinically suitable for treating photoreceptor dystrophies, Lamba et al first performed 
a subretinal transplantation of GFP-labelled hESCs-derived retinal cells into a mouse 
model of degenerating retina (Crx knockout mice) (Lamba et al., 2009). Within 2 to 
3 weeks of transplantation, electroretinalgraphic (ERG) analysis revealed that mice 
that received transplantation demonstrated a clear response to a flash of light. This 
suggests the formation of functional photoreceptors in the retina upon transplantation 
and indeed, histological examination of the eyes that received transplantation 
revealed the expression of rod photoreceptor markers recoverin and rhodopsin. 
Additionally, the transplanted hESCs-retinal cells expressed synaptic markers 
synaptophysin and PSD95 (postsynaptic density protein 95). This transplantation 
strategy relies on the transplantation of a mixture of cells derived from hESCs which 
could bring adverse side effects such as teratoma formation. In the following study, 
in order to develop a safe and efficient transplantation, the group transfected hESCs- 
or iPSCs- derived retinal cells with a lentivirus expressing GFP under the promoter 
of human inter-photoreceptor binding retinol binding protein (IRBP). IRBP is 
expressed during the early development of rod and cone photoreceptors and been 
reported to drive photoreceptor-specific genes in transgenic mice (Pepperberg et al., 
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1993). For this reason, retinal culture was transfected with IRBP-GFP in order to 
purify retinal cells that are capable of forming photoreceptors from contaminating 
cell populations in the culture. hESCs and iPSCs were transfected with the construct 
4 weeks after undergoing retinal differentiation. The retinal cell culture was FACS-
sorted based on the GFP expression and over 90% of the sorted population expressed 
Nrl, Crx and recoverin. Upon transplantation, IRBP-expressing cells integrated with 
the retina of wild type mice and further differentiated into mature photoreceptors 
expressing Otx2, rhodopsin and recoverin. It still remains unclear however, whether 
IRBP-expressing cells can survive and demonstrate functional integration upon 
transplantation into a mouse model with degenerating retina. In addition, in order for 
this to be viable for human application, purification of transplantable cells based on 
the surface markers expressions is prerequisite. 
 Retinal cells derived from mouse iPSCs have been shown to improve vision 
upon transplantation into rod deficient model of mouse (Rho-/- mouse). In this study, 
using FACs sorting, researchers removed residual proliferating cells from the retinal 
cultures derived from mouse iPSCs. Transplantation of this retinal culture showed no 
teratoma formation after 3 weeks of transplantation compared to transplantation of 
mixture culture which resulted in teratoma formation in 2 out 6 mice they 
transplanted (Tucker et al., 2011). The transplanted cells migrated to the ONL of the 
55 
 
retina where 6.4% of the cells integrated to develop the proper photoreceptor 
morphologies. In addition, the integrated cells expressed markers specific for rods 
(recoverin and rhodopsin), cones (blue/green opsin), rod outer segment (ROM-1) and 
synapse (synaptophysin). To analyse functional improvements after transplantation, 
ERG analysis of Rho-/- mice that received transplantation revealed an improvement 
in the b-wave amplitude 21 days after transplantation. In addition, the expression of 
nuclear c-FOS was observed in the interneurons of the inner nuclear layer (INL) 
which is produced when photoreceptors are stimulated by light (Huerta et al., 1997).  
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1.3.5. Futures for hESCs- and iPSCs- derived retinal therapy for 
patient suffering photoreceptor dystrophies 
 Above described studies raise the hope of developing a feasible hESCs- or 
iPSCs-based treatment for photoreceptor dystrophies. In order for this to be clinically 
acceptable for human trials, a suitable purification method for transplantable retinal 
cells is required. So far, purification of donor cells derived from iPSCs involves gene 
modification which is not acceptable for human use (Lamba et al., 2010). Although 
transplanting hESCs-derived retinal cells have shown to improve vision in animal 
models of LCA, this approach has the risk of developing teratoma by residual 
proliferating cells in the culture (Tucker et al., 2011). In order to overcome this 
problem, efforts have been made to find novel cell surface antigens specific for 
photoreceptor precursor cells. Sorting cells based on the surface antigen allows 
purification of a particular cell population without damaging the cells. Koso et al., 
observed that the expression of CD73 was absent during embryonic stage but 
increased dramatically until postnatal day 9 (Koso et al., 2009). These CD73 
expressing cells did not express the proliferating marker Ki67, demonstrating that 
CD73+ cells were postmitotic cells. Further analysis with immunocytochemistry 
revealed that the majority of CD73+ cells co-expressed with rhodopsin but did not 
with PKCα (bipolar marker). In addition, CD73+ cells exclusively expressed Nrl and 
Crx markers but not RPC markers such as Chx10 and Hes1. In addition, it was 
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revealed that transplantation of CD73+ enriched cells integrated better in the ONL of 
the retina after transplantation compared to retinal cells acquired from P0 rhoEGFP 
mice (Eberle et al., 2011). Microarray analysis of NrleGFP retina revealed that a 
novel cell surface antigen CD24 was also expressed by developing mouse retina 
(Lakowski et al., 2011). Indeed, FACs sorting cells from the developing mouse retina 
based on the expression of CD24 and CD73 proved to be a powerful purification 
strategy. Transplantation of cells sorted based on the CD73/CD24 in the subretial 
space of wild type mouse retina revealed an 18- and 2.3-fold increase in integration 
in the ONL compared to unsorted and NrlEGFP sorted cells respectively.  
Purification of hESCs- or iPSCs- derived retinal cells based on these cell 
surface antigens and their subsequent transplantation into animal models of 
photoreceptor dystrophies would be a milestone achievement and one huge step 
towards hESCs- and iPSCs- based human retinal cell therapy. 
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1.4. Low oxygen (O2) on human pluripotent stem cell 
differentiation 
1.4.1. O2 tension during early mammalian development and hypoxia-
inducible factors (HIFs) 
 During the early stages of mammalian development, embryos develop in the 
well- controlled environment of the uterus (Okazai and Maltepe, 2006). Among the 
important components, O2 tension has been reported to play a critical role on the 
embryonic development (Dunwoodie 2009). The uterus environment is considered to 
be hypoxic, as the O2 tension during the embryonic development is considerably 
lower than the atmospheric O2 tension (~20%) (Lee et al., 2001; Pringle et al., 2007). 
For instance, the human embryo develops in an environment where O2 tension ranges 
between 0 and ~3% until the start of the second trimester (Burton and Jaunaiux, 
2001) and other mammalian embryos experience a similar deficiency in the supply of 
O2 during the early developmental stages (e.g. rabbit 8.7% and monkey 1.5%) 
(Fischer and Bavister, 1993). Hypoxia seems to play a critical role in organogenesis 
as cells found in the heart, gut, lung, midbrain, pituitary, spinal cord and tongue of 
the E14.5 mouse embryo stained positive for a hypoxic marker Primonidazole 
(Dunwoodie, 2009). This was further supported when the exposure of the developing 
embryos to the atmospheric level was found to be detrimental to the development of 
key organs which led to embryonic lethality (Catt and Henman, 2000).  
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 In hypoxic conditions, the stabilization of hypoxia-inducible factor-1a (HIF-
1a) is a key feature of the cellular response (Wang et al., 1995). HIF-1a is subject to 
a proteasomal degradation under the atmospheric O2 but upon stabilization in 
hypoxic conditions, HIF-1α dimerizes with HIF-1β and the dimer binds to the 
hypoxic response element (HRE) to transactivate some 250 HIF target genes (Huang 
et al., 1996; Kallio et al., 1997). These genes are thought to be responsible for 
various cellular activities required for the adaption in the oxygen-deficient 
environment such as angiogenesis, erythropoiesis, energy metabolism and cell 
survival (Ke and Costa, 2006). The activation of these however, seems unlikely to 
take place at the same time when cells are exposed to hypoxia and it is more 
plausible that the transcriptional responses are context- and cell type- dependent. It 
has also been reported that stabilized HIFs can also function in a non-canonical 
pathway by a cross-talk with other signal pathways. Gustafsson et al extensively 
studied the interaction between HIF-1a and Notch signal pathway (Zheng et al., 
2008). Notch pathway is conserved across different species and plays important roles 
during development (Schweisguth, 2004). Notch pathway is activated when a ligand 
binds to the transmembrane Notch receptor which releases intracellular domain 
(ICD). ICD then translocates to the nucleus and activates downstream target genes of 
Notch such as Hes and Hey genes. The activation of Hes1 and Hey2 is enhanced 
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under hypoxic condition and it was revealed, by immunoprecipitation, that there is a 
physical interaction between HIF-1a and Notch 1 ICD (Gustafsson et al., 2005). It is 
thought that HIF-1a stabilizes Notch ICD to enhance its transcriptional activity. 
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1.4.2. Hypoxia and neuronal development 
 The stabilisation of HIF has been shown to be critical for the survival of the 
embryos and during organogenesis. By generating HIF-deficient mice, studies have 
demonstrated that embryos were morphologically abnormal as early as E8.5 and 
caused embryonic lethality by E10.5 (Ramirez-Bergeron et al., 2006). The 
histological analysis of embryos at E9.75 revealed defects in the development of 
vascularization such as dilated vascular structures and reduction in the overall 
number of cephalic blood. The involvement of HIF in the development of vascular 
structure has been studied in depth however, its role in the development of CNS 
remains unclear. By creating neural specific HIF-knockout mice, it has been 
demonstrated that HIF plays a critical role in the normal development of functional 
brain (Tomita et al., 2003). The mutant mice, although showed no external 
differences, had impaired spatial memory functions and a significantly reduced 
number of neuronal cells. 
The effect of hypoxia on neuronal developmental has been studied with 
many interests over the last 10 years. Cells from various parts of the brain were 
isolated and subject to hypoxic conditioning in an attempt to elucidate the effect of 
hypoxia on neurogenesis. Lowering O2 tension during the culture of ventral midbrain 
cells enhanced the generation of tyrosine-hydroxlase (TH) positive dopaminergic 
neurons across the different species (Milosevic et al., 2005; Studer et al., 2000). 
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Human neural crest stem cells (NCSCs) which have the capacity to differentiate into 
autonomic neurons in response to BMP exhibited an enhanced survival, proliferation 
and multilieange differentiation when cultured under 5% O2 (Morrison et al., 2000). 
Mesencephalic precursors derived from human fetal mesencephalon are capable of 
differentiating into dopamine neurons (DA). The O2 level of Interstitial tissue in the 
mammalian brain ranges between 0.55 and 8% (Erecinska and Silver, 2001). It has 
been demonstrated that mesencephalic precursors’ proliferative capacity is 
significantly enhance when cultured at 3% O2 in the presence of epidermal growth 
factors (EGF) and bGFG2 (Storch et al., 2001). In addition, it was observed that 
differentiating precursors derived from human fetal midbrain in the presence of brain 
derived neurotrophic factor (BDNF) and ascorbic acid for 21 days at 5% O2 resulted 
in up to 50% of total cells expressing MAP2- and TH- positive DA (Maciaczyk et al., 
2008). Human neural stem cells (hNSCs) isolated from diencephalic and telecephalic 
brain regions of fetus at 10.5 week gestational age showed an improved survival, 
proliferation and maintenance of an undifferentiated phenotype when cultured at 5% 
O2 tension (Santilli et al., 2010). 
Amongst 250 downstream targets of HIF, vascular endothelial growth factor 
(VEGF) is a well-known growth factor for the formation and maintenance of 
vascular structure (Marti and Risau, 1998; Shweiki et al., 1992). However, studies 
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have demonstrated that VEGF plays pleiotropic roles in promoting cellular growth, 
proliferation and protection in the CNS (Sanchez et al., 2010). The neurotrophic role 
of VEGF has been demonstrated when VEGF promoted neurite outgrowth and 
enhanced survival of dopaminergic neurons when applied to the fetal ventral 
mesencephalic explants (Jin et al., 2000; Rosenstein et al., 2003; Sondell et al., 2000). 
In addition, VEGF induces neurite growth and is a potent mitogen for astroglia and 
Schwann cells as well as mediates mouse RPCs proliferation in-vitro through VEGF 
receptor during mouse embryogenesis (Sondell et al., 1999; Yang and Cepko, 1996). 
Erythropoietin (EPO) is another downstream target of HIF-1a, widely known for its 
roles in the production of red blood cells (Semenza et al., 1991). The expression of 
EPO receptors in the developing mouse and human CNS supports a possible role for 
non-hematopoeitic functions of EPO. Indeed, recent studies have reported that EPO 
is required for normal brain development and its neurotrophic activity in the CNS is 
regulated by the O2 tension and tissue hypoxia (Juul et al., 1999; Yu et al., 2002). To 
support this, Pistollato et al demonstrated an enhanced proliferation of human CNS 
precursor cells at 5% compared to 20% which are accompanied by the expression of 
erythropoietin EPO that is required for neural precursor survival and expansion in 
vivo (Pistollato et al., 2007).  
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1.4.3 Hypoxia on pluripotency and differentiation of hESCs 
 Investigation of the effect of low oxygen on hESCs biology has attracted 
much attention in the last decade. Perhaps this comes as no surprise as all cells in the 
embryo are exposed to low oxygen and also differentiate during organogenesis at a 
reduced level of oxygen (see section 1.4.1). This presents oxygen tension as an 
important variable for many aspects of hESCs studies. The effect of hypoxia on the 
way hESCs behave is a context-dependent. Exposing cells kept in the self-renewing 
condition to lowered O2 tension revealed a better maintenance of pluripotency 
compared to cells exposed to 20% O2 (Ezashi et al., 2005; Forsyth et al., 2006; 
Zachar et al., 2010). Hypoxia seemed not to alter the expression of pluripontency 
genes directly, but transcriptomic analysis revealed widespread differences in the 
expression of pluripotency target genes between hypoxic and normoxic conditions 
(Forsyth et al., 2008; Westfall et al., 2008). Most notably, the upregulation of Lefty2 
was observed which is thought to prevent spontaneous differentiation of hESCs. 
Indeed, it was revealed by an independent study, that a greater heterogeneity was 
observed in cultures at 20% O2 compared to 5% culture (Ezashi et al., 2005). This 
heterogeneity could arise from subpopulations of colonies that may have already 
begun to differentiate at 20% O2. 
Numerous studies have attempted to investigate whether hESCs 
differentiation could be enhanced by exposing differentiating hESCs to the 
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physiological oxygen tension that the developing embryo experiences. Previously, 
effect of hypoxia on neuronal differentiation of mouse ESCs was investigated 
(Mondragon-Teran et al., 2009). The results revealed that 2% O2 failed to show any 
differences in the production of NSCs expressing Nestin. However, their subsequent 
differentiation into neuronal cells expressing bIII tubulin and MAP2 was 
significantly enhanced compared to the differentiation at 20% O2. In a similar study, 
mESCs were differentiated into NSCs under 20% O2 and their subsequent 
differentiation into oligodendrocyte was enhanced at 3.5% compared to 20% O2 as 
more DA cells expressing TH (Kim et al., 2008). This trend was also seen with 
neuronal differentiation of hESCs. Stacpoole et al (2011) demonstrated that neural 
conversion of hESCs to Nestin-expressing NSCs is not affected by lowering O2 
tension (3% O2). These NSCs were then directed to differentiate into midbrain 
dopaminergic and spinal motor neurons by adding FGF-8 for 1 week and FGF-8 with 
1mM purmorphamine for 1–2 weeks. qPCR analysis revealed that NSCs directed to 
differentiate at 3% O2 had a two- and five-fold increase in the expression level of 
OLIG2 and EN-1 respectively, both specific markers for motor neuron and midbrain 
dopaminergic neuron precursors (Stacpoole et al., 2011). Other lineage 
differentiations that have been reported to benefit from operating at a low O2 tension 
include chondrogenic and endothelial differentiation of hESCs and cardiac 
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differentiation of mESCs (Koay and Athanasion, 2008; Bianco et al 2009; Prado-
Lopez et al., 2010).   
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1.5. Summary 
Human pluripotent stem cells have the potential to differentiate into almost 
all types of cells in the body whilst maintaining the ability to self-renew (Section 
1.2.1 and 1.2.2). These unique properties are ideal for providing a platform for the 
development of a novel cell replacement therapy for treatment of currently incurable 
degenerative conditions. Retinitis pigmentosa (RP) is one example of a genetic 
condition that could benefit if the potential is to be realised (Section 1.1.2, table 1.1). 
Patients suffering from RP experience visual impairment due to degeneration of 
photoreceptors in the retina (Hartong et al., 2006). The condition remains untreatable 
however, recent studies have shown that clinically-viable retinal cells could be 
produced from human pluripotent stem cells (Lamba et al., 2010 and Section 1.3.1). 
Despite this promising development, clinical application of human pluripotent stem 
cells suffers from major drawbacks. Along with safety concerns, a consistent large 
scale production of specialized cells from human pluripotent stem cells remains a 
major hurdle to successful therapy (Gerecht-Nir and Itskovitz-Eldor, 2004; Oh and 
Choo, 2006). In order to develop a robust process for producing enough 
transplantable cells from human pluripotent stem cells for therapeutic purposes, it is 
important to optimize current differentiation protocols. They rely on the addition of 
growth factors that have been identified to play key roles in tissue development 
(Section 1.2.2). However, as described previously in Section 1.3, current 
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differentiation protocols are not only inefficient and lengthy, but their efficiency 
varies depending on the human pluripotent stem cells lines used. 
A few recent studies have demonstrated that mimicking the 
microenvironmental oxygen (O2) tension of the developing mammalian embryo 
could significantly increases pluripotent stem cell differentiation efficiencies into 
various lineages of cells (Section 1.4.3). The O2 concentration in the uterine 
environment ranges between 1 and 5% which is significantly lower than the 
atmospheric concentration (21%, see section 1.4.1). This is also the environment 
where organogenesis takes place therefore mimicking this O2 tension could have a 
significant impact on differentiation.  
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1.6 Hypothesis 
The hypothesis of this thesis is that mimicking physiological O2 tension 
enhances the generation of RPCs from human iPSCs and hESCs. In order to test the 
hypothesis, the study was divided into three major sections. 
 
Characterisation of hESCs and iPSCs. Chapter 3 characterizes two different 
human pluripotent stem cell lines used for this study. Characterisation is based on the 
expression of typical pluripotency genes, their ability to differentiate into three germ 
layer and karyotypic analysis. 
  
Retinal differentiation capacity of iPSCs and hESCs. Chapter 4 next compares 
production of RPCs from iPSCs and hESCs using an established differentiation 
protocol (Lamba et al., 2006). This is important to provide the control data against 
which any benefits of operation under hypoxic conditions can be quantified. 
 
Optimisation of RPC generation from hESCs and iPSCs. Chapter 5 investigates 
the role environmental oxygen plays in optimising retinal differentiation protocol. 
This is assessed in terms of the number and purity of cells expressing RPC markers.  
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In addition to the literature survey describing in this chapter, Chapter 2 covers all the 
materials and methods used during the investigation while Chapter 6 summarise the 
main conclusions and also provides suggestions for future work. 
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2.Materials and Methods 
2.1 Human Pluripotent Cell Culture 
Undifferentiated human pluripotent cells (MSUH001 iPSCs and Shef3 
hESCs were obtained from the Spanish and the UK Stem Cell Bank respectively), 
were grown on Mitomycin-C (1mg/ml, Sigma-Aldrich, Poole, UK) inactivated 
mouse embryo fibroblasts (MEF) in Knockout DMEM supplemented with 20% (v/v) 
Knockout serum replacement, 1mM L-glutamine, 1%(v/v) non-essential amino acids, 
100mM -mercaptoethanol, and 4ng/mL bFGF (all Invitrogen, Paisley, UK). They 
were cultured in a Sanyo IncuSafe incubator (Sanyo, MCO-18AIC, Leicestershire, 
UK) at 37℃ and 5%(v/v) CO2 and 5ml of fresh growth medium was exchanged 
every 24 hours. iPSCs were transferred to newly Mitomycin-C inactivated MEF 
every 3-4 days by dissecting colonies into smaller clumps with Fine Tip Mini 
Pastette (Alpha Laboratories, Hampshire, UK). hESCs colonies were dissected in the 
same way after incubating with 0.025mg/ml collagenase (Invitrogen) for 3 minutes at 
37℃.  
 
2.2 Isolation of MEF 
 Mouse embryos from the female at day 13 p.c. were obtained. Each embryo 
was separated from the placenta and surrounding membranes using sterile tweezers. 
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The embryo sac was cut open using a fine surgical scissors and the brain and dark 
organs were removed. The embryos were collected in PBS and finely minced before 
being incubated wit 2ml of Trypsin (Invitrogen) at 37℃ for 15 minutes. The 
supernatant was collected and resuspended in 2ml MEF medium that consists of 
DMEM supplemented with 10%(v/v) Foetal bovine serum (all from Invitrogen) and 
1%(v/v) NEAA (Gibco). This was subjected to a low speed centrifugation (1200rpm) 
for 3 minutes. The supernatant was removed and the pallet was resuspended in MEF 
before being plated in a T75 flask (Nunc) denoted as “P0”. 
 
2.3 Feeder preparation 
 When MEF reached between 70 and 80% confluency, they were inactivated 
with 9ml pre-diluted Mytomycin-C for 2 hours at 37ºC. The cells were then washed 
three times with 5ml DPBS and trypsinized for three minutes at 37ºC. The cells were 
then quenched with 3ml MEF medium and centrifuged at 1200rpm for 3 minutes. 
The supernatant was removed and the pallet was resuspended in 20ml MEF medium 
for cell counting before plating 250,000 cells/cm² in a T25 flask. 
 
2.4 Three germ layer differentiation 
  Human pluripotent stem cell colonies were removed from the feeder layers 
73 
 
and cultured in suspension for 15 days in the hES medium without bFGF. The 
subsequent EBs were subjected to immunocytochemistry in suspension as described 
in section 2.7. The list of primary and their corresponding secondary antibodies can 
be found in Table 2.1. The expression of the markers was observed with confocal 
microscopy (Perkin Elmer Ultraview Spinning Disk). 
 
2.5 Early Neural Retinal Differentiation of Human pluripotent 
Stem Cells 
Human pluripotent stem cells were induced to differentiate using a 
previously published protocol (Lamba et al., 2006). Briefly, undifferentiated 
pluripotent stem cell colonies were dissected into small clumps with Fine Tip Mini 
Pastette (Alpha Laboratories) and cultured as embryoid bodies (EBs) in suspension 
in 30mm non-adherent bacterial grade culture dishes (Sterilin, Caerphilly, UK) 
containing 3ml retinal induction medium consisting of DMEM/F12 supplemented 
with 10%(v/v) Knockout Serum Replacement (both Invitrogen), 1ng/ml human 
recombinant DKK-1, 1ng/ml human recombinant noggin, 5ng/ml human 
recombinant IGF-1 (all R&D Systems, Minneapolis, US) and 1%(v/v) N-2 
Supplement (PAA Laboratories Ltd, Yeovil, UK) for 3 days (Fig 2D). On day 4, 
approximately 30 EBs were selected under a dissecting microscope and plated in 
each well of a 6-well plate coated with Matrigel (BD Bioscience, San Diego, CA) 
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and cultured in DMEM/F12 (Invitrogen) supplemented with 10ng/ml human 
recombinant DKK-1, 10 ng/ml human recombinant IGF-1, 10ng/ml human 
recombinant Noggin, 5ng/ml basic fibroblast growth factor (all R&D Systems), 
1%(v/v) N-2 Supplement and 2%(v/v) B27 Supplement (PAA Laboratories Ltd) (Fig 
2.1F). 
 
2.6 Oxygen Tension Control 
The hypoxic chambers used in these studies had previously been fabricated 
to maintain 2% O2 during the neuronal differentiation mESCs (full description of 
construction and operation can be found in (Mondragon-Teran et al., 2009)). Briefly, 
undifferentiated pluripotent stem cell colonies were dissected into small clumps as 
described above before placing the cell culture dish into a hypoxic chamber. To 
maintain humidity within the chamber, a 30 mm petri dish (Sterilin, Caerphilly, UK) 
containing 3ml of distilled water was also placed in the chamber. The chamber was 
then gassed from a premixed gas cylinder composed of 2%(v/v) O2, 5%(v/v) CO2 
and 93%(v/v) N2 (BOC, Barking, UK) for 5 minutes before placing it in an incubator 
at 37℃ (Fig 2B). After 3 days, the culture dishes were removed from the chamber 
and plated into 6-well plates coated with Matrigel as described above before being 
returned to the chamber, gassed and placed back into the incubator (Fig 2C). The 
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medium was changed every 2 days during which the chamber was re-gassed.  
 
Figure 2 
 
Figure 2. Schematics of retinal differentiation of human pluripotent stem cells. (A) Human pluripotent 
stem cells were cultured in the presence of MEF to maintain pluripotency in the ambient O2 tension. 
(B) Colonies were removed from the feeder layer and cultured in suspension to form EBs for 3 days in 
the hypoxic chamber where 2% O2 was maintained. (C) After 3 days, subsequent EBs were plated on 
matrigel-caoted 6-well plate, again both in the hypoxic chamber and incubator. (D and E) EBs were 
also made in the normoxic conditions for 3 days and plated on a matrigel-coated 6-well plate.  
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2.7 Immunocytochemistry  
Cells were fixed with 2ml 4%(w/v) paraformaldehyde (PFA) for 20 minutes 
before being permeabilized with 0.25%(v/v) Triton X-100 in Dulbecco’s modified 
phosphate-buffered saline (PBS) for 10 minutes at room temperature (all from 
Sigma-Aldrich). The samples were washed with 2ml DPBS and incubated in 2ml 
blocking solution (2%(v/v) goat serum, 0.25%(v/v) Triton X-100 in PBS all from 
Sigma-Aldrich) for 30 minutes. For the detection of cell surface marker, the 
permeabilization step was omitted and cells were incubated straight into the blocking 
solution for 30 minutes. The samples were then incubated with 600l of primary 
antibodies diluted in blocking solution overnight at 4℃. The primary antibodies used 
were as follows; monoclonal mouse anti-Oct4 IgG (Invitrogen 1:400), monoclonal 
mouse anti-Tra-1-60 IgM (1:200), monoclonal mouse anti-SSEA3 IgM (1:200), 
polyclonal mouse anti-Nestin IgG (1:400), monoclonal mouse anti-Pax6 IgG (1:300), 
polyclonal rabbit anti-Otx2 (1:1000), monoclonal mouse-Neurofilament-M IgG 
(1:400), polyclonal rabbit anti-S-opsin (1:200), polyclonal rabbit anti-Nrl (1:200, all 
from Millipore, Hertfordshire, UK), polyclonal Rabbit anti-Chx10 IgG (Sigma-
Aldrich, 1:300), monoclonal mouse anti-rhodopsin (1:200), monoclonal mouse anti-
Prox1 (1:200), polyclonal goat anti-IRBP (1:200), polyclonal goat anti-Six3 (1:200), 
polyclonal goat anti-Lhx2 (1:200, all from Santa Cruz), monoclonal mouse anti-Crx 
(Abnova), monoclonal rabbit-anti-PKCα IgG (1:400, Abcam). The cells were then 
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washed with 2ml PBS three times and incubated with 600l of either Alexa Flour 
488 goat anti-mouse, Alexa Flour 488 goat anti-rat IgM, Alexa Flour 555 goat anti-
mouse (all Invitrogen, 1:400), and Cy3 conjugated donkey anti-rabbit IgG (Millipore, 
1:300) in blocking solution for 1 hour at room temperature (details of primary and 
secondary antibody combinations can be found in Table 2.1). The same concentration 
of the corresponding isotype controls were used as a negative control (murine IgM 
isotype control (Sigma-aldrich), mouse and rabbit IgG isotype control (both from 
Abcam)).The cells were washed three times with 2ml PBS and incubated with 4,6-
diamidino-2-phenylindole (DAPI, Invitrogen, 1:1000) in PBS for 5 minutes. 
Fluorescence images were acquired using a fluorescence microscope (Nikon, Eclipse 
TE2000-U) and analyzed with NIS-element software. Confocal images were taken 
with Perkin Elmer Ultraview Spinning Disk confocal microscope.  
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Table 2.1. The list of primary antibodies used and their corresponding secondary antibodies. 
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2.8 Detection of Pimonidazole Hydrochloride at 2% O2 
 The hypoxia marker pimonidazole hydrochloride (Hypoxyprobe-1 kit, HPI 
Inc., MA, USA) was used to demonstrate the exposure of cells to lowered O2 tension 
in the hypoxic chamber. iPSCs and hESCs were cultured at both 20% and 2% O2 for 
two days. 100μM pimonidazole was added two hours prior to fixation with 4% PFA. 
The fixed samples were blocked as previously described and incubated with anti-
pimonidazole mouse monoclonal antibody IgG1 (HPI Inc., 1:30 in PBS) or mouse 
IgG isotype control (Abcam) overnight at 4℃. The samples were washed with 1ml 
PBS and incubated with 600l of Alexa Flour 488 goat anti-mouse IgG (Invitrogen 
1:400) for two hours at room temperature. The samples were washed with 1ml PBS 
and incubated with DAPI (Invitrogen 1:1000) for two minutes in the dark before 
analysed by confocal microscopy. 
 
2.9 Flow Cytometry  
2.9.1 Cell surface markers 
Samples were washed with 2ml DPBS and incubated with 2ml Trysin 
(Invitrogen) for 10 minutes at 37℃. The cultures were quenched with DMEM 
containing 10% (v/v) FBS (Invitrogen) and physically dissociated by pupating 10 
times with a Pasteur pipette (Fisher Scientific, Leicestershire, UK). The dissociated 
cells were re-suspended in DMEM containing 10% (v/v) FBS and centrifuged for 3 
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minutes at 1200 rpm. The supernatant was removed and the pellet was re-suspended 
in 2ml of PBS. After centrifuging at the same conditions, the supernatant was 
removed and the cells were fixed with 0.5ml 4%(w/v) PFA for 20 minutes on ice. 
The cells were centrifuged at 1200rpm for 3 minutes and re-suspended in 0.5ml 
blocking solution (2%(v/v) goat serum in DPBS) for 30 minutes on ice. The cells 
were again centrifuged at the same condition and incubated with the blocking 
solution containing monoclonal mouse anti-Tra-1-60 IgM (1:200) and murine IgM 
isotope control (Sigma-Aldrich, 1:200) overnight at 4℃. The cells were washed 
twice with 1.5ml DPBS and incubated in blocking solution containing Alexa Flour 
488 goat anti-mouse IgM (Invitrogen) for two hours at room temperature. The cells 
were washed twice with 1.5ml DPBS before incubating with DAPI for three minutes. 
FACs analysis was then performed using a flow cytometer (CyAN ADP, 9 colour, 3 
laser analyser, Beckman Coulter, High Wycombe, UK). Dead cells and debris were 
excluded using forward and side scatter parameters and only single cell population 
was selected using the pulse width parameter. 99% of samples incubated with the 
isotype control and a secondary antibody was gated as a negative population. The 
data were analysed with Sumit v4.3 software (DAKO, Cambridgeshire, UK). 
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2.9.2 Intracellular markers 
After fixing cell with PFA, the cells were washed with DPBS and incubated 
with 0.5ml permeabilizing solution (0.25% Triton in DPBS) on ice for 10 minutes. 
After centrifugation, the cells were blocked in 0.5ml DPBS with 2%(v/v) goat serum, 
0.25%(v/v) triton for 30 minutes on ice before incubating overnight at 4C with 
blocking solution containing murine monoclonal IgM isotope control (1:200), 
monoclonal mouse anti-Oct4 IgG (1:400), monoclonal mouse anti-Pax6 IgG ( 1:300) 
and polyclonal Rabbit anti-Chx10 IgG (1:300). The cells were subjected to three 
DPBS washes before incubating with blocking solution containing Alexa Flour 488 
goat anti-mouse IgG and Alexa Flour 647 goat anti-rabbit IgG (Invitrogen) for two 
hours at room temperature. Isotype controls were used (same concentration as the 
primary antibodies) as a negative control (mouse and rabbit IgG isotype control (both 
from Abcam)). The cells were washed, counter-stained with DAPI and analysed as 
described above. 
 
2.10 RNA extraction and cDNA synthesis 
Total RNA extraction was achieved using the Qiagen RNeasy kit (Qiagen, 
Crawley, UK). Briefly, cell pellets were harvested using a cell scraper (TPP Techno 
Plastic Products AG, Switzerland), re-suspended and homogenized by aspirating 5 
times through an RNase-free syringe with an 18G needle in buffer RLT provided in 
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the kit. The samples were then processed in accordance with the manufacturer’s 
instructions. In the final step, RNA was eluted with 40μl of RNase-free water by 
centrifuging for 1 minute at 10,000 rpm. The RNA concentration was determined by 
measuring absorbance at 260 nm using a spectrophotometer (NanoDrop ND-1000, 
Thermo Scientific, Epson, UK). For cDNA synthesis, we used the Ambion 1st strand 
cDNA synthesis kit (RETROscript® Ambion, Warrington, UK) according to 
manufacturer’s instructions with 1μg of RNA for each reaction in a total reaction 
volume of 20μl.  
 
2.11 Real-time quantitative polymerase chain reaction (qPCR) 
qPCRs were performed using the MESA BLUE qPCR MasterMix Plus for 
SYBR® Assay (Eurogentec, Hampshire, UK) following the manufacturer’s 
instructions. All primer pairs were acquired from Qiagen which are listed in Table 
2.2. Each reaction contained 1μL of 1st strand cDNA in a total reaction volume of 
20μL and all measurements were taken in triplicate. The PCR conditions used were 
as follows; 2 minutes at 50C, 10 minutes at 95C, followed by 40 cycles at 95C for 
15 seconds, 55C for 30 seconds and 60C for 30 seconds. The final three steps were 
95C for 15 seconds, 60C for 15 seconds and 95C for 15 seconds. All samples 
were normalized to levels of β-actin (an endogenous housekeeping gene) and relative 
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quantification was carried out as previously described (Pfaffl, 2001). 
 
 
Table 2.2. The list of primers used for qPCR analysis. All the primers were acquired from Qiagen. 
 
2. 12 Statistical Analysis 
Triplicate samples were analysed in all experiments. The values are expressed as 
means ± standard error of the mean (S.E.M). To determine statistical significance, 
Paired Student’s T-tests were performed and P≤0.05 was considered significant. 
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3. Characterisation of MSUH001-iPSCs and Shef3-hESCs 
3.1. Introduction  
 Human pluripotent and embryonic stem cells are characterized by their 
ability to maintain (i) prolonged undifferentiated proliferation and (ii) developmental 
potential to form derivatives of all three embryonic germ layers (Thomson et al., 
1998). These unique properties are ideal for the development of novel cell 
replacement therapies for a numerous degenerative medical conditions (Oliveri and 
Anderson, 2008). Various laboratorial techniques are available to examine whether 
cells fulfill the criteria to be considered as pluripotent stem cells. Stage-specific 
embryonic antigens (SSEA)-3, SSEA-4, Tra-1-60 and Tra-1-81 are the classic cell 
surface markers that are present in undifferentiated cells (Carpenter et al, 2003). 
Immunocytochemistry or flow cytometry using antibodies raised against these 
markers is the commonly used method to characterize undifferentiated state of 
pluripotent stem cells (Thomson et al., 1998). In addition, the same technique can be 
performed with antibodies raised against pluripotency-associated transcription 
factors such as Oct4, Nanog and Sox2 (Loh et al., 2006).  
 Multi-lineage differentiation capacity of pluripotent stem cells can be 
demonstrated both in vitro and in vivo. Pluripotent stem cells spontaneously 
differentiate into cells representing three germ layers through EB formation in vitro 
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(Thomson et al., 1998; Reubinoff et al., 2000). EBs are formed when colonies are 
removed from the feeder layers and cultured in suspension without any growth 
factors. They form spheroid aggregates of cells that contain cells of all the three germ 
layers in a disorganized fashion (Chen et al., 2010). Transplanting pluripotent stem 
cells in immunodeficient (SCID) mice forms a tumour-like structure termed teratoma. 
Histological examination of teratoma reveals that it contained various tissues 
including cartilage (mesoderm), gut-like epithelial cells (endoderm) and neural 
tissues (ectoderm) (Thomson et al., 1998; Takahashi et al., 2007). Another in vivo 
method for the test of pluripotency is the generation of chimera. This method 
examines whether pluripotent stem cells contribute to the development of all adult 
tissues when injected into a recipient blastocyst (Evans and Kaufman, 1981). Due to 
ethical reason however, this technique cannot be carried out with primate ES cells.  
 
3.1.1. Aim 
 The aim of this chapter is to examine whether human induced pluripotent 
stem cell (MSUH001-iPSCs) and embryonic stem cell (Shef3-hESCs) lines fulfilled 
the essential criteria of pluripotent stem cells.  
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3.2. Characterization of MSUH001-iPSCs 
3.2.1. Morphology and undifferentiated state 
 The first human iPSCs lines were created by two independent groups in 
2007 (Takahashi et al., 2007; Yu et al., 2007). They genetically reprogrammed human 
somatic cells by forcefully expressing a combination of key pluripotency genes using 
viral transfection systems. iPSCs have revolutionized stem cell research due to their 
potential to create patient- and disease-specific pluripotent stem cells for cell 
replacement therapy (Nishikawa et al., 2008). In addition, they could provide a 
useful tool for understanding disease mechanism, drug screening and toxicity testing 
(Heng et al., 2009; Marchetto et al., 2011). In this experiment, MSUH001 (P11) 
iPSCs line was used, which had previously been generated in Jose Cibelli’s lab 
(Michigan State University) by expressing a combination of four factors (Oct4, Sox2, 
Nanog and Lin28) in human somatic fibroblasts (Yu et al., 2007). These cells were 
cultured in the presence of Mytomycin-C inactivated MEF feeder cells and grew as 
colonies of cells. After 5 passages, it was revealed that, although colonies were flat 
and round which are typical characteristic of human pluripotent stem cell colonies 
(Reubinoff et al., 2000), the culture contained a heterogeneous population of colonies 
based on their morphologies (Fig 3.1A). Further analysis with immunocytochemistry 
revealed that the culture contained three sub-populations of colonies based on the 
expression of Oct4 (Fig 3.1B). We identified colonies a type I sub-population that did 
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not express Oct4 (Fig 3.1B top row), a type II sub-population that partially expressed 
Oct4 (Fig 3.1B middle row) and a type III sub-population that expressed Oct4 (Fig 
3.1B bottom row). In order to obtain a homogeneous population of true pluripotent 
iPSCs colonies, colonies that morphologically belonged to the type III sub-
population were selectively passased (Fig 3.1B bottom row). Morphological analysis 
by phase contrast microscopy after 7 passages revealed that the most of colonies 
were round and flat, consisting of single cells with a high nucleus/cytoplasm ratio 
(Fig 3.2A). Immunocytochemistry confirmed that all the colonies expressed 
pluripotency and undifferentiated markers Oct4 and Tra-1-60 in the nucleus and 
membrane respectively (Fig 3.2C). Flow cytometry showed a high percentage of the 
population expressed Oct4 (92±1.56%) and Tra-1-60 (84±2.05%) (Fig 3.3A and B). 
This indicates that cells maintained undifferentiated state whilst they were 
propagated in culture. 
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Figure 3.1 
 
Figure 3.1. Heterogeneous population of MSUH001-iPSCs culture. (A) Morphologically different 
colonies were present in the culture after 5 passages from thawing P11 MSUH001-iPSCs. (B) Three 
sub-populations of colonies were identified based on Oct4 expression. They were colonies that did not 
express Oct4 (top panel), colonies that partially expressed Oct4 (middle panel) and colonies that 
expressed Oct4 (bottom panel). 
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Figure 3.2 
 
Figure 3.2 Characterization of MSUH001-iPSCs. (A) iPSCs were cultured in the presence of MEF 
feeder layer to maintain pluripotency. They exhibited round and compact colonies, consisted of tightly 
packed single cells. (B) DAPI counter-staining for nucleus. (C) The colonies expressed 
undifferentiated stem cell makers Oct4 and Tra-1-60 in the nucleus and membrane respectively 
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Figure 3.3 
 
Figure 3.3 Flow cytometry analysis of Oct4 and Tra-1-60 expression level. (A and B) Flow cytometry 
analysis revealed that iPSCs expressed a high level of Oct4 and Tra-1-60 respectively. Each histogram 
represents a negative population stained with the corresponding isotype and a secondary antibody 
(blank) and samples stained with a primary and a secondary antibody (dashed). 
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3.2.2. Pluripotency of MSUH001-iPSCs 
 To examine whether iPSCs spontaneously differentiate into three germ 
layers, iPSCs colonies were removed from the feeder layer and cultured in 
suspension without bFGF for 10 days. They began to form a spheroid structure 
termed EBs on D2 of suspension culture and they were fixed on D10 to analyze 
expression of the germ layer markers. Immunocytochemistry revealed that EBs 
contained cells positive for Nestin (ectoderm lineage), Brachyury (mesoderm 
lineage) and Sox17 (endoderm lineage) without any preferred trajectories (Fig 3.4). 
 
Figure 3.4 
 
Figure 3.4 Three germ layer differentiation of MSUH001-iPSCs. iPSCs colonies were detached from 
the feeder layer and cultured for 10 days in suspension as EBs in DMEM supplemented with 10% 
KOSR. The EBs differentiated into (A) ectoderm, (B) mesoderm and (C) endoderm. 
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3.2.3. Karyotype analysis 
 In order to ensure the safety of stem cell based therapy, it is essential to 
check whether cells maintain the correct number and structure of chromosomes. 
Pluripotent stem cells are prone to chromosomal changes and transplantation of 
differentiated cells from pluripotent stem cells carrying abnormal chromosomes leads 
to the formation of a cancer-like structure (Moon et al., 2011(a)). Our karyotype 
analysis revealed that iPSCs were karyotypically normal (Fig 3.5). 
Figure 3.5 
 
Figure 3.5 Karyotype analysis of MSUH001-iPSCs (P34). The cells were karyotypically normal with 
the correction number of chromosomes. 
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3.3. Characterization of Shef3-hESCs 
3.3.1. Morphology and undifferentiated state 
 hESCs were first established in 1998 by isolating the inner cell mass from 
the human blastocyst (Thomson et al., 1998). In line with iPSCs culture system, 
hESCs are typically cultured in the presence of MEF feeder layers to support 
undifferentiated state in the culture. However, this culture condition is viewed as 
inappropriate for clinical purposes due to cross contamination between the two 
species (Mallon et al., 2006). For this reason, hESCs have also been cultured with 
human embryonic fibroblasts (HEFs) or in feeder-free culture system using 
commercially available extracellular matrices (Amit et al., 2003; Hernandez et al., 
2010). hESCs have long been thought as an ideal source materials for cell 
replacement therapy and over a decade of research have led to the first clinical trial 
of hESCs based therapy (see table 1.2). In this experiment, we used Shef3-hESCs 
which were co-cultured with Mytomycin-C inactivated MEF feeder cells. Two days 
after transferring to new feeder cells, they formed colonies that exhibited typical 
hESCs morphology of flat and round colonies tightly packed with single hESCs (Fig 
3.6A) (Reubinoff et al., 2000). All the colonies in the culture expressed pluripotency 
and undifferentiated markers Oct4 and Tra-1-60 detected by immunocytochemistry 
(Fig 3.6C) and flow cytometry revealed that cultures contained a high percentage of 
Oct4 and Tra-1-60 expressing cells (Fig 3.7A and B). 
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Figure 3.6 
 
Figure 3.6 Characterisation of Shef3-hESCs. (A) hESCs maintained on MEF feeder layer formed 
round, tightly packed, compact colonies (B and C) Immunocytochemical analysis showed that hESCs 
expressed undifferentiated markers Oct4 and Tra-1-60 in the nucleus and cytoplasm respectively. (D 
and E) Flow Cytometry analysis of the undifferentiated markers (Oct4 and Tra-1-60) expression level 
hESCs expressed high level of each marker. Each histogram represents a negative population stained 
with the corresponding isotype and a secondary antibody (blank) and samples stained with a primary 
and a secondary antibody (dashed). 
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Figure 3.7 
 
Figure 3.7 Flow cytometry analysis of Oct4 and Tra-1-60 expression level. (A and B) Flow 
Cytometry analysis of the undifferentiated markers (Oct4 and Tra-1-60) revealed that hESCs 
expressed high level of each marker. Each histogram represents a negative population stained with the 
corresponding isotype and a secondary antibody (blank) and samples stained with a primary and a 
secondary antibody (dashed). 
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3.3.2. Pluripotency of Shef3-hESCs 
 Shef3-hESCs were allowed to spontaneously differentiate into cells 
representing all three embryonic germ layers through EB formation. The colonies 
were removed from the feeder layer and cultured in suspension in the same condition 
as iPSCs-EBs. They began to form spheroid aggregates of cells D2 after suspension 
culture and were allowed to grow until D10 when immunocytochemistry was 
performed to analyse the expression of three germ layer markers. The analysis 
revealed that Nestin-positive cells, representing ectodermal lineage, were localized 
throughout the surface of EBs (Fig 3.6.). Brachyury- and Sox17- positive cells, 
representing mesoderm and endoderm respectively, were also generated after 
culturing EBs for 10 days (Fig 3.8). 
 
Figure 3.8 
 
Figure 3.8 Three germ layer differentiation of Shef3-hESCs. hESCs colonies were detached from the 
feeder layer and cultured for 10 days in suspension as EBs in DMEM supplemented with 10% KOSR. 
The EBs differentiated into (A) ectoderm, (B) mesoderm and (C) endoderm. 
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3.3.3. Karyotype analysis 
 Karyotype analysis of Shef3-hESCs revealed that cells were karyotypically 
normal, maintaining the correct number and structure of chromosomes during the 
culture (Fig 3.9). 
 
Figure 3.9 
 
Figure 3.9 Karyotype analysis of Shef3-hESCs (P55). The cells were karyotypically normal with the 
correction number of chromosomes. 
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3.4. Discussion 
 Under the appropriate culture regimes, human iPSCs and hESCs have the 
property to differentiate into any types of cells in the body thus, making them an 
ideal source material for cell replacement therapy. Prior to any differentiation studies, 
it is essential to evaluate cells maintain this potential and are uncommitted to any 
lineages differentiation until they receive differentiation stimuli. In this chapter, we 
demonstrated that two human pluripotent stem cell lines remained undifferentiated in 
the culture whilst maintaining the ability to differentiate into all three embryonic 
germ layers. MSUH-iPSCs and Shef3-hESCs lines were chosen because the cell 
lines have been well characterized, exhibiting all the aspects of true human 
pluripotent stem cell characteristics (MSUH001-iPSCs by the Cibelli’s group, 
Michigan State University and the Spanish Stem Cell Bank, and Shef3-hESCs by the 
Andrew’s group, Sheffield University and the UK Stem Cell Bank). For this reason, 
it was decided that these cell lines provide a good candidate for examining the effect 
of lowering O2 tension during retinal differentiation (see chapter 4 and 5). 
This evaluation was particularly important for characterization of 
MSUH001-iPSCs line. Shef3-hESCs culture was seemingly homogenous in 
appearance, exhibiting typical morphology of hESCs colonies (Fig 3.6A). In addition, 
immunocytochemistry and flow cytometry showed that the culture expressed a high 
percentage of Oct and Tra-1-80 (Fig 3.7A and B) and differentiated into cells 
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representing all three embryonic germ layers (Fig 3.8).  
MSUH001-iPSCs culture however, contained a mixture of morphologically 
varable hESCs-like colonies which led us to investigate the identity of different 
looking colonies. Immunocytochemistry against Oct4 revealed that the culture 
contained a mixture of colonies that did not express (type I), partially expressed (type 
II) and fully expressed Oct4 (type III) (Fig 3.1B). The heterogeneicy nature of human 
pluripotent stem cell culture could severely hinder their ability to generate specific 
types of cells. It was revealed that fibroblasts that are partially reprogrammed to 
exhibit hESCs-like morphology failed to form teratoma or differentiate into all three 
embryonic germ layers (Chan et al., 2009). In order to obtain a homogenous 
population of fully reprogrammed cell colonies, we selectively picked colonies that 
exhibited type III colony morphology and expanded further (Fig 3.1B bottom row). 
After 7 passages, our immunocytochemistry and flow cytometry revealed a 
comparable expression level of Oct4 and Tra-1-80 to Shef3-hESCs (Fig 3.3A and B). 
In addition, when colonies were removed from the feeder layer and cultured in 
suspension in the absences of bFGF, they differentiated cell representing all three 
embryonic germ layers, confirming the pluripotent nature of the cells (Fig 3.4).   
It has been revealed that reprogramming efficiency is very low and cultures 
are thought to be heterogeneous, containing mixed population of none, partially and 
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fully reprogrammed cells despite acquiring hES-like morphology (Chan et al., 2009). 
It has been believed that reprogramming techniques are still to be optimized (Feng et 
al., 2009). In addition, one study revealed that not all fibroblasts are susceptible to 
reprogramming. The researchers revealed that only a small population of cells termed 
multilineage-differentiating stress-enduring (Muse) cells within human fibroblast 
population exclusively reprogrammed to become true iPSCs (Wakao et al., 2011). 
Efforts have been made to enhance reprogramming efficiency using various methods 
that include novel gene delivery systems and the use of low O2 during 
reprogramming processes (see section 1.2.2.3 and Yoshida et al., 2009).  
 
3.5 Conclusion 
In this chapter, it was confirmed that the two human pluripotent stem cell 
lines MSUH001-iPSCs and Shef3-hESCs exhibit the true characteristics of 
pluripotent stem cells and could be used as a starting material for the generation of 
retinal cells which are described in detail in the next chapter.  
 
 
 
 
101 
 
4. Generation of RPCs from MSUH001-iPSCs and 
Shef3-hESCs 
4.1. Introduction 
Human pluripotent stem cells hold the promise for developing a novel 
treatment for currently incurable degenerative medical conditions (Oliveri and 
Anderson, 2006). One of the conditions that can be benefited from stem cell 
based therapy is genetic ocular diseases such as retinitis pigmentosa (RP) that 
is characterized by the loss of photoreceptors in the retina (see section 1.1.2). 
Using combinations of forebrain inducing growth factors such as DKK-1 (wnt 
pathway antagonist), Noggin (BMP pathway antagonist) and Lefty A (nodal pathway 
antagonist), it has been possible to generate RPCs from pluripotent stem cells with 
varying efficiencies (Lamba et al., 2006; Osakada et al., 2008; Meyer et al., 2010). 
Generating RPCs from human pluripotent stem cells has opened a new paradigm for 
the treatment of photoreceptor dystrophic conditions. In particular, Lamba et al. 
generated ~80% RPCs co-expressing RPC markers Pax6 and Chx10 21 days after 
plating hESCs-EBs (Lamba et al., 2006). Further studies revealed that transplanting 
photoreceptor precursor cells derived from RPCs significantly improved vision in 
photoreceptor-deficiency mice (Lamba et al., 2010). Despite the promising evidence, 
it is a widely accepted that differentiation efficiency varies greatly between different 
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pluripotent stem cell lines (Osakada et al., 2008), thus may result in lower yield of 
target cells. The Lamba protocol was chosen because when this study was conducted, 
only two retinal differentiation protocols were available (see section 1.3). The retinal 
differentiation by Takahashi group was lengthy involving complicated steps whereas 
the Lamba protocol seemed more reproducible, thus the latter protocol was chosen. 
 
4.1.1. Aim 
 The aim of this chapter is to evaluate whether MSUH001-iPSCs and Shef3-
hESCs are suitable cells lines for generating RPCs with a comparable efficiency 
using the Lamba protocol. This chapter provides the control data against which any 
benefits of operation under hypoxic conditions can be quantified in the following 
chapter. 
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4.2. Generation of RPCs from MSUH001-iPSCs 
4.2.1. EB formation and induction of early eye field gene  
 iPSCs colonies were removed from the feeder layer and cultured in 
suspension in the medium supplemented with DKK-1, Noggin and IGF-1 for 3 days. 
The floating colonies of cells formed aggregates of cells after 1 day being in 
suspension culture that further developed into a spheroid structure on day 3 (Fig 
4.1A). To examine whether the supplement of the growth factor favoured the 
induction of early eye field genes, we analysed the expression level of early eye field 
genes Six3 and Lhx2. These are early eye field genes required for retinal 
specification and optic cup development respectively and has been reported that 
Lhx2 defines presumptive retina field and transactivates Six3 expression in the same 
domain (Tetreault et al., 2009; Liu et al., 2010). The qPCR analysis revealed that 
supplement of the growth factors significantly increased the expression level of Six3 
by a 2.2 fold compared to EBs differentiating without the growth factors (Fig 4.1B, 
p≤0.05). Although the expression level of Lhx2 in EBs differentiating in the presence 
of the growth factor increased compared to EB differentiating without the growth 
factors, the increase deemed to be statistically not significant (Fig 4.1B).  
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Figure 4.1 iPSCs-EB formation and activation of the early eye field genes. A) iPSCs-EB formation in 
the presence of DKK-1, Noggin and IGF-1 was observed for three days. B) The expression level of 
the early eye field genes Six3 and Lhx2 in iPSCs-EBs formed in the presence of the growth factors 
(RPC) was compared to spontaneously differentiating iPSCs-EBs (S.D). The analysis revealed a 
significant increase in Six3 expression in iPSCs-EBs formed with growth factors compared to 
spontaneously differentiating iPSCs-EBs (p p≤0.05, n=3). However, a small increase was observed for 
Lhx2 which deemed to be insignificant compared to spontaneously differentiating iPSCs-EBs. 
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4.2.2. Adherent retinal differentiation of iPSCs-EBs 
After culturing EBs for 3 days in suspension, EBs were transferred to 
Matrigel-coated wells for the development of retinal cells. For this adherent culture, 
KOSR was withdrawn and N2 supplement and bFGF were additionally 
supplemented which have been thought to promote photoreceptor differentiation 
(Hicks and Courtois, 1992). Three days after plating EBs, cells migrated as tightly 
packed neuroepithelial cells from the site at which the EBs had attached in a similar 
pattern as previously observed (Fig 4.2A, Meyer et al., 2009). Some cells expressed a 
neural stem cell marker Nestin, suggesting that they had begun to differentiate into 
neuroectodermal lineage (Fig 4.2A bottom). At this time point, some cells in the EBs 
still expressed pluripotency marker Oct4 (Fig 4.2A middle). 6 days after plating EBs, 
it was observed that EBs continued to differentiate into Nestin-positive cells but 
some populations of cells were still positive for Oct4 (Fig 4.2B). 10 days after 
plating EBs, densely-packed populations of cells arranged in a radial manner, termed 
as neural rosettes due to their resemblance to early neural tube development (Zhang 
et al., 2001) formed in close proximity to the original site of attachment (Fig 4.2C 
asterisks). Cells around the rosettes were still positive for Oct4 and Nestin (Fig 4.2C 
middle and bottom). 17 days after plating EBs, it was revealed that cells no longer 
showed positive staining for both Nestin and Oct4 (Fig 4.2D). Cells did not show 
positive staining for RPC markers Pax6 and Chx10 at all the time points data not 
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shown 
 
Figure 4.2 
 
Figure 4.2 Expression of pluripotency (Oct4) and neural stem cell marker (Nestin) during the 
adherent differentiation. 3 days post plating iPSCs-EBs, many cells still expressed Oct4 where EBs 
were attached. At the same time point, it was also evident that EBs had already differentiated into 
Nestin positive neural stem cells. 6 days post plating, cells developing from the attached EBs were 
predominantly Nestin positive neural stem cells and although Oct4-positive cells were still present. 10 
days post plating saw the formation of neural rosettes (C asterisks) that were both Oct4- and Nestin-
negative but surrounding cells still expressed the proteins. Both proteins were undetectable from 17 
days post plating. 
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4.2.3. Generation of Pax6 and Chx10 co-expressing RPCs from iPSCs 
 Pax6 and Chx10 are key transcription factors required for RPC multipotency 
and proliferation (Liu et al., 1994; Marquardt et al., 2001) and it has been shown that 
cells expressing these can be generated from human pluripotent stem cells 21 days 
after plating EBs in the presence of DKK-1, Noggin and IGF-1 (Lamba et al., 2006). 
Using immunocytochemistry, we confirmed the generation of RPCs co-expressing 
Pax6 and Chx10 from MSUH001-iPSCs. The areas of Pax6 positive cells were 
abundant throughout the culture but only a few Pax6-positive colonies co-expressed 
Chx10 (Fig 4.3). Quantification of iPSCs-RPCs using flow cytometry revealed that 
74±4.6% were Pax6 positive, 31±2.8% expressed chx10 and 31±2.1% co-expressed 
Pax6 and Chx10 21 days after plating EBs (Fig 4.4A and B). The expression of rod 
precursor marker Nrl and mature photoreceptor markers S-Opsin and Rhodopsin 
were also investigated by immunocytochemistry but they were undetectable, 
suggesting that the differentiation culture period was not sufficiently long enough 
(data now shown). At the same time point, we performed qPCR to examine whether 
retinal genes were induced from pluripotent iPSCs. It was observed that there was a 
significant 3.7- and 11.2- fold increase in the expression level of Pax6 and Chx10 
respectively compared to pluripotent iPSCs (p≤0.05 Fig 4.5). Rx, another member of 
early eye field genes known to play roles in the retinal development, showed a 
significant increase compared to pluripotent iPSCs (5.9 fold increase, p≤0.05 Fig 4.5). 
108 
 
However, at this time point there were no significant increases in the expression 
levels of early eye field markers such as Lhx2, Otx2 and Six3 compared to 
pluripotent iPSCs (p>0.05 in all cases). 
 
Figure 4.3 
 
Figure 4.3 Analysis of Pax6 and Chx10 co-expressing RPCs 21 days post plating EBs using 
immunocytochemistry. Representative images of colonies co-expressing Pax6 and Chx10 
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Figure 4.4 
 
Figure 4.4. Flow cytometry analysis of Pax6 and Chx10 expression level. (A and B) The percentage 
of Pax6 and Chx10 expressing cells 21 days after plating EBs. Each histogram represents a population 
stained with the corresponding isotype and secondary antibody (blank) and with primary and 
secondary (dashed). The standard error is shown as a result of three independent experiments (n=3). 
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Figure 4.5 
Figure 4.5. Relative mRNA expression of the retinal markers 21 days after plating iPSCs-EBs. The 
expression level of RPC markers Pax6 and Chx10 significantly increased compared to pluripotent 
iPSCs 21 days post plating EBs. Out of the early eye field markers, only Rx showed a significant 
increase in the expression level compared to pluripotent iPSCs. The blue and red bars represent 
pluripotent iPSCs and retinal differentiation of iPSCs respectively. 
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4.3. Generation of RPCs from Shef3-hESCs 
4.3.1. EB formation and induction of early eye field genes 
 Shef3-hESCs were removed from the MEF feeder layer and formed EBs in 
the presence of the same growth factors. They formed EBs which were 
indistinguishable in terms of size and morphology from iPSCs-EBs after 3 days in 
suspension culture (Fig 4.6A). Analysis of the expression level of Six3 and Lhx2 by 
qPCR revealed a significant 2.3 fold increase in the expression level of Six3 in EBs 
differentiating with the growth factors compared to spontaneously differentiating 
EBs (p≤0.05 Fig 4.6B). This pattern is consistent with iPSCs-EBs differentiation in 
the presence of the growth factors. Unexpectedly, the expression level of Lhx2 
decreased in EBs differentiating with the growth factors compared to spontaneously 
differentiating EBs though this decrease was statistically not significant (Fig 4.6B). 
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Figure 4.6 
 
 
Figure 4.6 hESCs-EB formation and activation of the early eye field genes. A) hESCs-EB formation 
in the presence of DKK-1, Noggin and IGF-1 was observed for three days. B) The expression level of 
the early eye field genes Six3 and Lhx2 in hESCs-EBs formed in the presence of the growth factors 
(RPC) was compared to spontaneously differentiating hESCs-EBs (S.D). The analysis revealed a 
significant increase in Six3 expression in hESCs-EBs formed with growth factors compared to 
spontaneously differentiating hESCs-EBs (p p≤0.05, n=3). However, Lhx2 expression level decreased 
in hESCs-EBs formed in the presence of the growth factors compared to spontaneously differentiating 
hESCs-EBs although the decrease was statistically not significant. The blue and red bar represents 
Six3 and Lhx2 expression level respectively. 
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4.3.2. Adherent retinal differentiation of Shef3-EBs 
 3 days after plating hESCs-EBs, there appeared to be a few neurite processes 
on the peripheral region of the attached EBs (Fig 4.7A arrow). Immunocytochemistry 
at this time point revealed that EBs contained a small population of Oct4-positive 
cells and the majority of cells expressed Nestin (Fig 4.7A middle and bottom). The 
same observation was made 6 days after plating EBs as the culture contained a 
mixture of cells stained positive for Oct4 and Nestin, although Oct4-positive cells 
were sparsely populated (Fig 4.5B). Twelve days after plating EBs, neural rosettes 
were formed (Fig 4.7 asterisks) and the majority of cells expressed Nestin and only 
very small populations of cell expressed Oct4 (Fig 4.7C). The expression of Oct4 and 
Nestin was completely down-regulated 18 days after plating EBs and the 
morphology became increasingly difficult to define using phase contrast microscopy 
as cells became multilayered (Fig 4.7D). In consistent with differentiation of iPSCs-
EBs, cultures did not show positive staining for Pax6 and Chx10 at all the time 
points (date not shown). 
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Figure 4.7 
 
Figure 4.7 Expression of Oct4 and Nestin during adherent differentiation of hESCs-EBs. 3 days 
posting hESCs-EBs, small population of Oct4 positive cells were observed and the majority of cells 
developing from the plated hESCs-EBs were Nestin-positive cells. These markers were still present 8 
days post plating EBs and 12 days post plating hESCs-EBs saw the formation of neural rosettes. By 
this time point, Oct4-positive cells were very sparse and many cell expressed Nestin. Both markers 
were undetectable 18 post plating. 
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4.3.3. Generation of Pax6 and Chx10 co-expressing RPCs from hESCs 
 Performing immunocytochemistry 21 days after plating EBs revealed that, in 
consistent with iPSCs differentiation, a large population of cells expressed Pax6 (Fig 
4.8A). However, it was visually confirmed that cells co-expressing Pax6 and Chx10 
were rare within in the culture (Fig 4.8A-C). Indeed, quantification using flow 
cytometry revealed that only 1% of the cultures co-expressed Pax6 and Chx10 (Fig 
4.9A and B). To find out whether cells with retinal genotype had produced from 
pluripotent hESCs, we analyzed the expression level of early eye field and RPC 
genes 21 days after plating EBs. The analysis revealed a significant 9.9- and 9.4- fold 
increase in the expression level of Pax6 and Chx10 respectively when compared to 
pluripotent hESCs (Fig 4.10). In consistent with iPSCs differentiation, the expression 
level of Rx also increased 21 days after plating EBs but this increase were found to 
be statistically not significant. Surprisingly, Lhx2 which is expressed during the early 
stage of retinal development, was up-regulated in the differentiating cells compared 
to pluripotent hESCs 21 days after plating EBs (8.7-fold increase, p≤0.05, Fig 4.10). 
Retinal genes associated with early eye field specification (Otx2 and Six3) were 
significantly down-regulated at the end of D21 differentiation, suggesting that retinal 
differentiation had surpassed early retinal specification stage (p≤0.01, Fig 4.10) 
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Figure 4.8 
 
Figure 4.8 Analysis of Pax6 and Chx10 co-expressing RPCs 21 days post plating EBs. (A) 
Representative images of colonies co-expressing Pax6 and Chx10. (B and C) enlarged image of Pax6 
and Chx10 co-expressing cells.  
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Figure 4.9 
 
Figure 4.9. Flow cytometry analysis of Pax6 and Chx10 expression level. (A and B) The percentage 
of Pax6 and Chx10 expressing cells. Each histogram represents a population stained with the 
corresponding isotype and secondary antibody (blank) and with primary and secondary (dashed). The 
standard error is shown as a result of three independent experiments (n=3). 
 
 
 
 
 
 
 
 
 
 
 
118 
 
Figure 4.10 
 
Figure 4.10. Relative mRNA expression of the retinal markers 21 days after plating hESCs-EBs. The 
expression level of RPC markers Pax6 and Chx10 significantly increased compared to pluripotent 
hESCs 21 days post plating EBs. Out of the early eye field markers, only Lhx2 showed a significant 
increase in the expression level compared to pluripotent hESCs. The blue and red bar represents 
pluripotent and retinal differentiation of Shef3-hESCs respectively. 
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4.4. Discussion 
 Since the establishment of human pluripotent stem cells, many protocols 
have been developed to generate specific cell types for potential therapeutic 
application. However, it is often found that differentiation protocols are cell line 
dependent as differentiation efficiency varies greatly across the different human 
pluripotent stem cell lines. In 2006, Lamba et al. developed the first differentiation 
protocol for generating RPCs from H1 hESCs line (the first hESCs line created by 
Thomson’s group in 1998). The protocol involves the application of various growth 
factors such as DKK-1, Noggin and IGF-1 that are reported to induce forebrain 
development during early mammalian development (Lamba et al., 2006). The results 
demonstrated the generation of ~80% RPCs co-expressing RPC markers Pax6 and 
Chx10 and this protocol was validated using three different iPSCs lines with a 
comparable efficiency. In this chapter, it was first examined in the lab, whether the 
Lamba differentiation protocol can be applied to generate RPCs from Shef3-hESCs 
and MSUH001-iPSCs lines with a comparable efficiency. In this chapter, it was 
confirmed 1) that both cell lines failed to achieve a comparable RPC differentiation 
efficiency as H1-hESCs line, 2) differences in the morphological characteristics 
during retinal differentiation and 3) that MSUH001-iPSCs line differentiated into 
RPCs better than Shef3-hESCs. 
 The protocol consists of two stages; the first stage involves culturing cells as 
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floating aggregates termed EBs for first three days and the second stage involves an 
adherent culture of EBs for 21 days after the EB stage. iPSCs- and hESCs-EBs 
formed in the presence of the growth factors were morphologically indistinguishable 
(Fig 4.1A and 4.6A). The expression level of Six3, a gene expressed during early eye 
field specification, significantly increased compared to spontaneously differentiating 
EBs without the growth factors (Fig 4.1B and 4.6B). Lhx2, another gene reportedly 
required for the early eye field specification did not show any significant changes in 
the expression level in EBs differentiated with growth factors compared to 
spontaneously differentiating EBs (Fig 4.1B and 4.6B). This was the phenomenon 
observed in both MSUH001-iPSCs and Shef3-hESCs lines, suggesting that the 
protocol is effective in inducing Six3 expression 3 days after culturing EBs (Fig 4.1B 
and 4.6B). 
Both cell lines were indistinguishable genotypically and phenotypically 
during the first stage of the protocol but differences were observed between the cell 
lines during the adherent culture of EBs. We observed morphological differences 
when both pluripotent cell types were induced to differentiate into Pax6 and Chx10 
co-expressing RPCs. When hESCs-EBs were plated, spindle cells with neurite 
processes developed on the peripheral region of the attached EBs (Fig 4.7 arrow). 
However, the development of this neuronal morphology was not observed when 
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iPSCs-EBs were attached. Instead, cells migrated outwards from the attached site as 
tightly packed neuroepithelial colonies similar to those observed in a previous study 
(Fig 4.2A). The expression profile of Oct4 and Nestin was similar between the two 
cell lines during the differentiation. However, it was noticeable that the population of 
Oct4-positive cells was visually more abundantly sustained throughout the 
differentiation period up to 15 days after plating iPSCs-EBs compared to hESCs-EBs 
(Fig 4.2 and 4.7).  
21 days post plating EBs, it was revealed the generation of RPCs co-
expressing Pax6 and Chx10 through performing immunocytochemistry. To quantify 
the percentage of RPCs generated, flow cytometry was performed to reveal retinal 
differentiation of Shef3-hESCs was inefficient, generating just over 1% of RPCs co-
expressing Pax6 and Chx10 (Fig 4.6D). In contrast, iPSCs generated more cells 
expressing Pax6 and Chx10 (31±2.1%) at the same condition (Fig 4.3B).  
Reasons for variations in differentiation efficiency across the different cell 
lines are subject to much debate. It has been reported that during embryogenesis, the 
ICM is heterogeneous as early as embryonic day 3.5 (E3.5) when subsets of cells 
begin to differentiate into primitive endoderm and epiblast (Chazaud, 2006). This 
early differentiation commitment of the ICM has been confirmed in a recent study 
which showed a differential expression of GATA6 (primitive endoderm marker) and 
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Nanog (pluripotency marker) in mESCs (Singh, 2007). As the primary culture of  
hESCs involves isolation of clumps of cells from this heterogenous ICM as opposed 
to from a single parental cell, in vitro ESC cultures always contain populations of 
ESCs with different developmental potentials (Shamblott, 1998; Thomson., 1998; 
Reubinoff., 2000). An earlier study by Osakada et al. (Osakada et al., 2008) revealed 
significant variation in the efficiency between two hESCs lines during the retinal 
differentiation. This may indicate that heterogeneous ESCs contain a subpopulation 
of cells which are refractory to retinal differentiation. We have hypothesized that 
differences between MSUH001-iPSCs and Shef3-hESCs may be due to amount of 
refractory cells present in each cell type. In addition it is possible that the 
reprogramming process may enhance the retinal differentiation of the pluripotent 
cells derived.  
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4.5 Conclusion 
It is genuinely believed that the Lamba retinal differentiation protocol works 
best with the cell line it was developed with. This was clearly demonstrated when 
MSUH001-iPSCs and Shef3-hESCs failed to achieve the similar retinal 
differentiation efficiency to H1-hESCs. Furthermore, as the differentiation efficiency 
was relatively low for these two cell lines, it requires a generic method that is 
applicable to a wide range of cell lines. Recent studies have shown that lowering O2 
tension has generic benefits in enhancing the production of specific cell types from 
human pluripotent stem cells (see section 1.5). In the next chapter, the effect of 
lowered O2 tension will be examined on retinal differentiation of MSHU001-iPSCs 
and Shef3-hESCs.  
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5. The effect of hypoxia on the generation of RPCs from 
iPSCs and hESCs 
5.1. Introduction 
For human pluripotent stem cells to become clinically viable, it is critical to 
efficiently differentiate these cells into the desired cell types. Current strategies to 
induce differentiation into a particular lineage have tended to rely on mimicking the 
events that take place during the early mammalian development through the addition 
of pathway agonists and antagonists (Vazin and Freed, 2010). Differentiating cells 
are exposed to atmospheric oxygen (O2) tension (~20%), which is significantly 
higher than the hypoxic environment experienced by developing human (~3%) and 
mammalian embryos (rabbit 8.7% and monkey 1.5%) (Fischer and Barister, 1994; 
Burton and Jaunaiux, 2001). Recent studies have shown that mimicking 
physiological O2 tension can greatly influence embryonic stem cell (ESC) biology. 
Culturing human ESCs (hESCs) at 3-5% O2 resulted in better maintenance of 
pluripotency marker expression, reduced levels of spontaneous differentiation and a 
decrease in the frequency of chromosomal abnormalities (Ezashi et al., 2005; Forsyth 
et al., 2006; Zachar et al., 2010). It has also been reported that low O2 enhances 
endothelial, chondrogenic and neuronal differentiation of hESCs and neural and 
cardiac differentiation of mouse ESCs (mESC) (see section 1.4.3). 
125 
 
A number of studies have also mimicked O2 tensions present in adult organs 
during the culture of adult stem cells. Low O2 tension in the brain is conserved 
amongst mammalian species. In the rat brain, O2 tension varies at different locations 
(white cortex 0.8%-2.1%, hypothalamus 1.4%-2.1% and hippocampus 2.6%) 
(Erecinska and Silver, 2001) as with human brain (3.2% under and 4.4% above the 
dura) (Ding et al., 1998). The subventricular zone (SVZ) is the main neurogenic 
niche in the human brain where neural stem cells (NSCs) are responsible for adult 
neurogenesis (Lim and Alvarez-Buylla, 1998). The O2 tension of the human SVZ has 
never been directly measured however, it is widely accepted that NSCs reside in 
areas of relatively low O2 tension. This is further supported by studies showing that 
human NSCs showed improved survival, proliferation and maintenance of an 
undifferentiated phenotype when cultured at 5% O2 tension (Santilli et al., 2011). 
Low O2 tensions also exist in other adult stem cell niches such as bone marrow, a 
source of hematopoietic (HSCs) and mesenchymal stem cells (MSCs) (Mohyeldin et 
al., 2010). Indeed, there is evidence that lower O2 tension promotes the maintenance 
of an undifferentiated state in cultured bone marrow-derived MSCs (Cipolleschi et al., 
1995; Fehrer et al., 2007). Taken together these studies have revealed that mimicking 
in-vivo O2 tensions can be used to enhance the undifferentiated expansion and 
directed differentiation of both pluripotent and adult stem cells. 
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5.2. Aim 
In this study, it was sought to improve the differentiation of human 
pluripotent stem cells into retinal progenitor cells (RPCs) by lowering O2 tension. A 
previously reported retinal differentiation protocol (see chapter 4) was used to 
examine the effect of lowering O2 tension on early neural retinal differentiation of 
iPSCs and hESCs. It was previously shown that 2% O2 tension increases neuronal 
differentiation efficiency of mESCs (Mondragon-Teran et al., 2009). This O2 tension 
is used during retinal differentiation of the two cell lines to observe whether low 
efficiency observed in the previous chapter could be enhanced to produce higher 
percentage of Pax6 and Chx10 co-expressing RPCs.  
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5.3. Detection of hypoxia in cells exposed to 2% O₂ 
Pimonidazole hydrochloride is a widely used hypoxic marker for detection 
of hypoxia both in-vitro and in-vivo due to its chemical stability and solubility in 
water (Raleigh et al., 1985). In the cells exposed to low O2 tension, pimonidazole 
hydrochloride forms adducts with thiol groups in proteins whose immunoreactive 
side chain can be immunochemically analyzed using a monoclonal antibody raised 
against the adducts (Cline et al., 1990). Two human pluripotent stem cell lines were 
cultured at 2% O2 for two days in the hypoxic chamber stained positively for 
hypoxyprobe-1 whereas those cultured at 20% O2 were negative (Fig 5.1E-F). The 
exposure of human cells to O2 tensions below 21% O2 leads to the stabilization of 
HIF-1a and the activation of over 250 downstream genes including vascular 
endothelial growth factor (VEGF) and lactate dehydrogenase (LDHA) (Ke and Costa, 
2006). We next investigated whether 2% O2 had led to the expression of HIF-1a 
responsive gene VEGF in human pluripotent stem cells exposed to 2% O2 for two 
days. The analysis revealed a similar fold increase in the expression level of VEGF 
in both iPSCs and hESCs (2.2 and 2.3 fold increase respectively, p≤0.05, Fig 5.1G 
and H) exposed to 2% O2 compared to cells cultured under 21% O2. This provides 
supporting evidence cells cultured in the hypoxic chambers at 2% O2 (Mondragon-
Teran et al., 2009) were exposed to hypoxic conditions. 
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Figure 5.1 
 
Figure 5.1 Validation of the hypoxic chamber. Confocal analysis of hypoxia marker in the cells 
exposed to 2% O2. (A and B) Isotype control and (C and D) cells cultured at 20% O2 for two days 
stained negatively for pimonidazole staining. (E and F) Cells cultured at 2% O2 for two days however, 
stained positively for pimonidazole.  
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Figure 5.2 
 
Figure 5.2. The activation of HIF-1a target gene VEGF. iPSCs and hESCs were cultured in the 
chamber for 6 days and qPCR was performed. The analysis revealed a significant 2.3 fold increased in 
the expression level of VEGF in both (A) iPSCs and (B) hESCs cultured in the chamber compared to 
those cultured at 20 % O2. 
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5.4. Activation of HIF responsive genes and retinal specification in 
EBs derived from iPSCs (iPSCs-EBs) 
 Clinical application of ESCs-based cell therapy is often perceived as 
unethical due to the use of embryos and has drawbacks such as immune rejection. 
iPSC based cell therapies would circumvent the use of embryos and may minimise 
the risk of immune rejection through treating patients with their own cells 
(Rolletschek and Wobus, 2009). Therefore we examined whether lowering O2 
tension had a beneficial impact on the early neural retinal differentiation of iPSCs. 
EB formation is a widely used technique in the initial stage of pluripotent stem cell 
differentiation (Thomson et al., 1998). iPSCs colonies were dissected into small 
clumps and cultured in suspension for 3 days to form EBs at 20% and 2% O2 in the 
presence of eye field inducing factors (Fig 2.1B and D). The expression level of 
pluripotency genes in EBs formed under both O2 tensions was comparable to that of 
pluripotent iPSCs (Fig. 5.3A). Although qPCR analysis of Oct4 and Nanog revealed 
that their expression was lower at 2% compared to 20% O2, these results were not 
significant. Immunocytochemistry of D3 EBs revealed that many cells formed in 
both conditions remained Oct4-positive (Fig. 5.3B) indicting that 2% O2 did not 
affect the down-regulation of pluripotency markers in EBs differentiated in the 
presence of DKK-1, Noggin and IGF-1. 
The exposure of human cells to O2 tensions below 21% O2 leads to the 
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stabilization of HIF-1a and the activation of over 250 downstream genes including 
vascular endothelial growth factor (VEGF) and lactate dehydrogenase (LDHA) (Ke 
and Costa, 2006). We next investigated whether 2% O2 had led to the expression of 
HIF-1a responsive genes VEGF and LDHA in EBs exposed to 2% O2 for 3 days. 
qPCR analysis showed a significant 3.2- fold increase in VEGF expression and a 4.8- 
fold increase in LDHA expression in EBs formed at 2% O2 compared to 20% O2 (p≤
0.05 in both cases, Fig. 5.4A and B). The results confirm that EBs cultured at 2% O2 
for 3 days in the presence DKK-1, Noggin and IGF led to the up-regulation of HIF-
1a responsive genes, most probably through O2 dependent stabilization of HIF-1a. 
Next, to determine whether lowered O2 tension acts in synergy with the 
growth factors to induce the retinal specification of pluripotent cells, we performed 
qPCR on D3 EBs to determine the expression level of Six3 and Lhx2 which are two 
genes required for early eye field formation (Tetreault et al., 2009; Lie et al., 2010). 
The analysis revealed that there was a 2.2 fold increase (p≤0.05) in Six3 expression 
when EBs were differentiated at 20% O2 in the presence of DKK-1, Noggin and IGF-
1 compared to spontaneously differentiating EBs controls at 20% O2 in the absence 
of any growth factors (Fig. 5.5A). However, we observed a bigger margin of increase 
in the expression level of Six3 when EBs differentiated with all growth factors at 2% 
O2 compared to spontaneously differentiating EBs at 20% O2 (3.1 fold increase, p≤
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0.05, Fig. 5.5A). We observed a similar phenomenon with Lhx2 expression level. 
The expression level of Lhx2 in EBs differentiated with growth factors at 20% O2 
was 1.2 fold higher than that in the spontaneously differentiating EBs (not significant, 
p>0.05, Fig. 5.5B). However, Lhx2 expression level significantly increased when 
EBs differentiated in the presence of all growth factors at 2% O2 compared to 
spontaneously differentiating EBs at 20% O2 (2.5 fold increase, p≤0.05, Fig.5.5B).  
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Figure 5.3 
 
Figure 5.3 Expression of pluripotency genes in D3 iPSCs-EBs cultured in both O2 conditions. (A) 
Differentiating iPSCs-EBs in the presence of the growth factors for 3 days in both O₂ conditions 
showed a comparable expression level of pluripotency genes to the control pluripotent iPSCs. (B) 
Confocal microscopy revealed that iPSCs-EBs formed in both O2 conditions in the presence of the 
growth factors were aggregates of Oct4-positive cells after 3 days of suspension culture. The blue and 
red bar represents the expression level of Oct4 and Nanog respectively. 
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Figure 5.4 
 
Figure 5.4. Relative expression level of HIF-1aresponsive genes. (A and B) qPCR analysis of LDHA 
and VEGF expression level in iPSCs-EBs formed at 2% compared to 20% O₂ in the presence of the 
growth factors. 
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Figure 5.5 
 
Figure 5.5 Relative expression level of early eye field genes Six3 and Lhx2. (A and B) qPCR analysis 
of the gene expression levels in iPSCs-EBs differentiated in the presence of growth factors at 20% and 
2% O₂ relative to spontaneously differentiating control iPSCs-EBs at 20% O₂. 
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5.5. Effect of lowered O₂ tension on generation of RPCs derived 
from iPSCs (iPSCs-RPCs) 
3 days after plating EBs, cells migrated as tightly packed neuroepithelial 
cells from the site at which the EBs had attached under both conditions in a similar 
pattern as previously observed (Figure 5.6B) (Meyer et al., 2009). 8 days after 
plating EBs, densely-packed populations of cells arranged in a radial manner, termed 
as neural rosettes due to their resemblance to early neural tube development (Zhang 
et al., 2001) formed in close proximity to the original site of attachment at 2% O2 
(Fig 5.6B, arrows). At 20% O2 neural rosettes did not form until 10 days after plating 
(Fig 5.6A). The morphology of cells under both conditions became multilayered and 
indistinguishable 17 days after plating EBs (Fig 5.6A and B). 
Pax6 and Chx10 are key transcription factors required for RPC multipotency 
and proliferation (Liu et al., 1994; Marquardt et al., 2001) and it has been shown that 
cells co-expressing these markers can be generated from human pluripotent stem 
cells 21 days after plating EBs in the presence of DKK-1, Noggin and IGF-1 (Lamba 
et al., 2006) (see chapter 4). Using immunocytochemistry, we found that cells co-
expressing RPC markers Pax6 and Chx10 were visually more abundant at 2% O2 
relative to 20% O2 21 days after plating EBs (Fig 5.7A and B). At 20% O2, the areas 
of Pax6 positive cells were abundant throughout the culture but only a few colonies 
co-expressed Chx10 (Fig 5.7A). Pax6 positive cells were also abundant in the culture 
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at 2% O2 (Fig 5.7) but more colonies co-expressing Pax6 and Chx10 were observed 
at 2% O2 as compared to 20% O₂ (Fig 5.7B).  
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Figure 5.6 
 
 
Figure 5.6 Generation of RPCs from iPSCs at 20% and 2% O₂. (A) Morphological analysis retinal 
differentiation of iPSCs at 20% O2 tensions. Representative images were taken on D3, D6, D10 and 
D17 after plating iPSCs-EBs.(B) Morphological analysis of iPSCs-EBs at 2% O₂. Representative 
images were taken on D3, D8, D10 and D17 after plating iPSCs-EBs. Arrows indicate neural rosette 
formation. Neural rosettes were formed 10 and 8 days post plating EBs at 20% and 2% O₂ 
respectively..  
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Figure 5.7 
 
 
 
Figure 5.7 Representative images of colonies co-expressing Pax6 and Chx10 at 20% O₂ (A) and 2% 
O₂ (B).  
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Quantification of iPSCs-RPCs using flow cytometry revealed that at 20% O2, 
74±4.6% were Pax6 positive and 31±2.8% of the culture expressed chx10 21 days 
after plating EBs (Fig 5.8 A and B). At 2% O2, there was a slight increase in the 
percentage of cells expressing Pax6 (80±3.8%) although this rise was not found to be 
significant (p>0.05 Fig 5.8C). Culture at 2% O2 was associated with significant rises 
in the percentage of cells expressing Chx10 (55±3.7% p≤0.05, Fig 5.8D). The 
majority of these Chx10 expressing cells also expressed Pax6 and their percentage 
also significantly increased at 2% compared to 20% O2 (54±1.3% p≤0.05, Fig 5.9A 
and B). These results confirm our earlier observation using immunocytochemistry 
and quantify the improvements in RPC formation which can be achieved at 2% O2. 
At the same time point, cells expressing other retinal markers such as Otx2, Lhx2 
and Six3 were also observed by immunocytochemistry but no visible differences 
were found between the two conditions (Fig 5.10). 
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Figure 5.8 
 
 
Figure 5.8 Comparison between RPC generation at 20 and 2% O₂. (A and B) Flow cytometry 
analysis of Pax6 and Chx10 expression level at 20% O₂. (C and D) Flow cytometry for Pax6 and 
Chx10 expression level at 2% O₂. Each histogram represents a population stained with the 
corresponding isotype and secondary antibody (blank) and with primary.  
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Figure 5.9 
 
 
Fig 5.9. (A and B) Dot plots revealed that the majority of cells expressing Chx10 also expressed Pax6, 
thus represent a true RPC population. (C) Immunucytochemistry was performed with an antibody 
raised against bipolar marker PKCα at the end of D21 post plating EBs at both O2 tensions. No 
immunoactivity against PCKα meant that Chx10 expression is RPCs.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
143 
 
Figure 5.10 
 
Figure 5.10. Immunocytochemistry for other retinal markers. (A and B) Immuocytochemistry was 
performed with antibodies against Pax6, Otx2, Six3 and Lhx2 at 20% and 2% O2 respectively. In 
accordance with qPCR data, these markers were also detectable at the protein level and no significant 
differences were observed between the two conditions. 
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21 days after plating EBs, our qPCR analysis revealed no significant 
increases in the expression levels of early eye field markers such as Lhx2, Otx2, Six3 
and Rx at 2% vs 20% O2 (p>0.05 in all cases). However, a significant 1.2- and 3.8- 
fold increase in the expression level of Pax6 and Chx10 at 2% O2 respectively 
relative to 20% O2 (Fig 5.11). This does not however indicate that at 2% O2 culture, 
many Chx10 positive cells are not co-expressing Pax6. As seen before with flow 
cytometry data (Fig 5.8), there is a small difference in the expression level of Pax6 
between the two conditions and much larger increase in the expression of Chx10. As 
we revealed all the Chx10-positive cells co-expressed Pax6 (Fig 5.9A and B), we can 
now confidently say that an increase in the expression level of Chx10 corresponds to 
Pax6/Chx10 co-expressing RPC populations. This was further supported when we 
detected no immunoactivity to an antibody raised against PKCα 21 days after 
plating EBs in both conditions as Chx10 is also a marker for mature bipolar cells (Fig 
5.9C). However, at the same time point, we showed the expression of Neurofilament-
M (a marker for ganglion cells) and Prox-1 (a marker for horizontal cells) in both 
conditions (Fig 5.12). This coincides well with the early retinal development as 
RPCs sequentially differentiate into ganglion, cones and horizontal cells first, then 
rods and amacrine cells followed by muller glial and bipolar cells. We failed to detect 
PKCα and markers for mature photoreceptors (S-opsin and Rhodopsin) may signify 
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that retinal differentiation was prematurely terminated 21 days after plating EBs. 
However, we detected a small number of cells co-expressing Crx (a cone precursor 
maker) and IRBP (interphotoreceptor retinoid binding protein) 21 days after plating 
EBs at 2% O2 (Fig 5.12). These cells were however, not found in 20% O2 culture, 
carefully suggesting that lowered O2 may favour the development of cone 
photoreceptors over other types of retinal neurons. The timing of the appearance of 
Crx/IRBP positive cells also correlates well with the early retinal development as 
cones are the first retinal neuron to be generated along with ganglion and horizontal 
cells from RPCs. The inability of lowered O₂ to significantly increase the expression 
level of these late retinal markers suggests that lowered O₂ is selectively acting on 
the early stages of retinal differentiation. 
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Figure 5.11 
 
Figure 5.11.Relative mRNA expression of the retinal markers 21 days after plating iPSCs-EBs at 20% 
and 2% O2. Compared to the control 20% O2 differentiation, 2% O2 induced an increase in the 
expression level of the early eye field genes (Otx2, Lhx2, Six3 and Rx) but without any statistical 
significance (p>0.05). However, a significant increase was observed in the expression level of RPC 
markers Pax6 and Chx10 under 2% compared to 20% O2 culture (p≤0.05 for Pax6 and p≤0.01 for 
Chx10, n=3). The blue and red bar represents retinal differentiation of MSUH001-iPSCs at 20% and 
2% O₂ respectively 21 days after plating EBs. 
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Figure 5.12 
 
Figure 5.12. Multilineage differentiation of iPSCs-RPCs at 20% and 2% O2. Immunocytochemistry to 
antibodies raised against ganglion (Neurofilament-M), horizontal (Prox1) and photoreceptor (Crx and 
IRBP) makers at both conditions. 
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5.6 Generation of RPCs from hESCs (hESCs-RPCs) under 20% and 
2% O₂ 
hESCs colonies were removed from the feeder layer and cultured in 
suspension in the presence of the same growth factors for 3 days in both O₂ tensions 
(Fig. 2.1 B). In line with iPSCs-EBs, no significant down-regulation of pluripotency 
gene expressions was observed in EBs cultured at both O₂ tensions compared to 
spontaneously differentiating EBs at 20% O₂ (Fig 5.13A). In addition, most of cells 
in EBs expressed Oct4 in both O2 tensions (Fig. 5.13B). It was observed that a 
significant 2.1 fold increase (p≤0.05) in the expression level of HIF-1a target gene 
VEGF in EBs cultured at 2% compared to 20% O₂ (Fig. 5.14).  
 3 days after plating hESCs-EBs at 2% O2, the cultures contained spindle-like 
cells which formed extensive neurite networks on the periphery of the attached EBs 
(Fig. 5.15, arrows). Although the same spindle cells were visible at 20% O2, there 
appeared to be fewer neurite processes in comparison to 2% O2 culture (Fig. 5.15A 
and B, arrows). Neural rosettes were formed 8 days after plating EBs at 2% O2 which 
did not appear until 12 days after plating EBs at 20% O2 (Fig. 5.15A and B, asterisks). 
18 days after plating EBs the morphology became increasingly difficult to define 
using phase contrast microscopy as cells became multilayered in both O2 conditions.  
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Figure 5.13 
 
Figure 5.13 Expression of pluripotency genes in D3 hESCs-EBs cultured in both O2 conditions. (A) 
Differentiating hESCs-EBs in the presence of the growth factors for 3 days in both O₂ conditions 
showed a comparable expression level of pluripotency genes to the control pluripotent hESCs. (B) 
Confocal microscopy revealed that hESCs-EBs formed in both O2 conditions in the presence of the 
growth factors were aggregates of Oct4-positive cells after 3 days of suspension culture. The blue and 
red bar represents the expression level of Oct4 and Nanog. 
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Figure 5.14 
 
Fig 5.14. qPCR gene expression level analysis of HIF-1a responsive gene VEGF. Relative expression 
level of HIF-responsive gene VEGF in hESCs-EBs formed at 2% compared to 20% O₂ in the presence 
of the growth factors. 
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Figure 5.15 
 
 
Figure 5.15 Generation of RPCs from hESCs at 20 and 2% O₂. (A) Morphological analysis retinal 
differentiation of iPSCs at 20% O2 tensions. Representative images were taken on D3, D8, D12 and 
D18 after plating hESCs-EBs. (B) Morphological analysis of retinal differentiation at 2% O2, images 
takens on D3, D8, D12 and D18 after plating hESCs-EBs. Arrows indicatene neuronal processes and 
Asterisks represent neural rosette formation 10 and 8 days post plating hESCs-EBs at 20% and 2% O2 
tensions respectively. 
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To examine the effect of lowered O2 tension on early neural retinal 
differentiation of hESCs, immunocytochemistry was performed 21 days after plating 
EBs. At 20% O2 there were large areas of Pax6-positive cells and only a small 
population of these cells co-expressed Chx10 confining to densely populated clusters 
of cells in close proximity to where EBs had attached (Fig. 5.16 A to C). At 2% O2, 
Pax6 positive cells were also abundant but noticeably more of these cells co-
expressed Chx10 (Fig. 5.16 D to G). 
 To quantify Pax6 and Chx10 co-expressing RPCs at both conditions, we 
used flow cytometry. This analysis revealed that at 2% O2, significantly more cells 
expressed Pax6 (52±5.1%, p≤0.05) and Chx10 (24±5.1%, p≤0.05, Fig. 5.17B and 
C) when compared to 20% O2 controls (Fig. 5.17A and BThese results confirm 
earlier observation using immunocytochemistry and quantify the improvements in 
RPC formation which can be achieved at 2% O2. 
 Expression levels of early eye field and RPC markers wereobserved fourteen 
days after plating hESCs-EBs, the expression level of all the genes increased at 2% 
O2 in comparison to 20% O₂ but only Pax6 and Chx10 were statistically significant 
(P≤0.01 and p≤0.05 respectively, Fig. 5.18), indicating that lowered O₂ tension 
enhanced transcription of RPC markers.  
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Figure 5.16 
D21 post- plating at 20% O₂ 
 
D21 post-plating at 2% O₂ 
 
Figure 5.16. Generation of Pax6 and Chx10 co-expressing RPCs from hESCs at 2% O₂. 
Representative images of colonies co-expressing Pax6 and Chx10 at 2% O₂. (B-C) Higher 
magnification of colonies co-expressing Pax6 and Chx10. (E)  
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Figure 5.17 
 
Figure 5.17. Comparison between RPC generation at 20% and 2% O₂ 21 days after plating EBs. (A 
and B) Quantification using flow cytometry revealed that the expression of Pax6 and Chx10 increased 
at 20% O₂. (C and D) It was revealed that the expression of both markers increased when 
differentiation took place at 2% O₂. Each histogram represents a poplation of stained with the 
corresponding isotype and secondary antibody (Blank) and with primary and secondary (dashed). The 
standard error is shown as a result of three independent experiments (n=3). 
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Figure 5.18 
 
Fig 5.18. Quantitative analysis of relative mRNA expression of the early eye field and RPC markers 
of hESCs-RPCs. Statistically significant increase in the Pax6 and Chx10 mRNA expression was seen 
at 2% relative to 20% O2 14 days after plating EBs (p≤0.01 for Pax6 and p≤0.05 for Chx10, n=3). The 
blue and red bar represents retinal differentiation of Shef3-hESCs at 20% and 2% O₂ respectively 21 
days after plating EBs. 
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5.8. Discussion 
 In ocular genetic disorders, such as retinitis pigmentosa (RP), degeneration 
of photoreceptors leads to many forms of visual impairment from progressive vision 
loss to, in most severe cases, a complete blindness (Hartong et al., 2006). To date, 
these conditions remain untreatable. However efforts have been made to restore 
vision by means of transplanting post-mitotic photoreceptor precursors (McLaren et 
al., 2006; Lamba et al., 2010). Human pluripotent stem cells are an ideal source for 
generating transplantable retinal cells as they are capable of producing almost all 
types of cells in the body (Thomson et al., 1998). Using combinations of forebrain 
inducing growth factors such as DKK-1 (wnt pathway antagonist), Noggin (BMP 
pathway antagonist) and Lefty A (nodal pathway antagonist), it has been possible to 
generate RPCs from pluripotent stem cells with varying efficiencies (Lamba et al., 
2006; Meyer et al., 2009; Osakada et al., 2008). In particular, Lamba et al. generated 
~80% RPCs co-expressing RPC markers Pax6 and Chx10 21 days after plating 
hESCs-EBs (Lamba et al., 2006). In this present study, we have shown that the 
efficiency of this RPC differentiation protocol is cell line dependent and can be 
enhanced by lowering O2 tension.  
Organogenesis in mammalian embryos takes place in a low O2 environment 
(~2-4% O2) (Burton and Jaunaiux, 2001) and we have shown that mimicking this O2 
tension has a significant impact in inducing key retinal genes during differentiation. 
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Lhx2 and Six3 are early eye field genes required for retinal specification and optic 
cup development respectively (Tetreault et al., 2009; Liu et al., 2010). It has been 
reported that Lhx2 defines presumptive retina field and transactivates Six3 
expression in the same domain (Tetreault et al., 2009). We have observed a non-
significant increase in the expression level of Lhx2 in EBs differentiating at 20% O2 
in the presence of DKK-1, Noggin and IGF-1 compared to spontaneously 
differentiating EBs 20% O2 (p>0.05 Fig 5.5B). However, the expression level 
significantly increased at 2% O2 when EBs differentiated in the presence of the 
growth factors compared to spontaneously differentiating EBs at 20% O2 (Fig 5.5B). 
The increase in the expression level of Lhx coincided with an increase in Six3 
expression at 2% compared to 20% O2 in the presence of the growth factors (Fig 
5.5A), indicating that lowering O2 to 2% acts synergistically with DKK-1, Noggin 
and IGF-1 to enhance the early retinal specification of iPSCs. 
When iPSCs- and hESCs-EBs were plated for 21 days in both O2 tensions, 
we observed the formation of neural rosette at an earlier time point at 2% O2 
compared to 20% O2 (Fig 5.6 arrows and 5.16 asterisk). This suggests that 20% O2 
may delay the development of neural lineages cells from human pluripotent stem 
cells. In addition, there was a significant increase in the population of cells co-
expressing Pax6 and Chx10 under 2% O2 compared to 20% O2 21 days after plating 
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iPSCs- and hESCs-EBs (Fig 5.8 and 5.17). Although the percentage of hESCs-RPCs 
was lower in comparison to iPSCs-RPCs, lowering O2 tension increased the 
efficiency of RPC formation from both pluripotent cells types. Increasing 
differentiation efficiency of pluripotent stem cells in various lineages of cells under 
low O2 (~2-5%) have been reported (Mondragon-Teran et al., 2009; Prado-Lopez et 
al., 2010; Stacpoole et al., 2011). In the case of neuronal differentiation, the 
efficiency was analysed by looking at pan neuronal markers such as BIII tubulin and 
MAP2 (Mondragon-Teran et al., 2009; Stacpoole et al., 2011). Here, we have shown 
that lowered O2 tension could also be used to enhance generation of a specific 
population of progenitor cells in the central nervous system (CNS), which are 
capable of producing all six types of retinal neurons and glia cells (Young, 1985). 
 The exact mechanism of hypoxia on retinal differentiation requires further 
investigation but it has been reported that hypoxic conditions are critical for CNS 
development (Nyakas et al., 1996). Hypoxia inducible factor (HIF) pathway is 
activated by lower O2 tension and studies of HIF knockout mice revealed embryonic 
lethality at E10.5 accompanied with neural tube defect and cell death within the 
cephalic mesenchyme (Iyer et al., 1998; Kotch et al., 1999). Vascular endothelial 
growth factor (VEGF) is a downstream target of HIF pathway (Marti and Risau, 
1998; Shweiki et al., 1992). Although it is a well known growth factor for the 
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formation and maintenance of vascular structure (Ferrara et al., 2003; Grunewald et 
al., 2006), it also participates in neurogenesis via VEGFR2/Flk-1 receptor (Jin et al., 
2002) and plays a significant role in developing the normal retina (Ishida et al., 2003; 
Stalmans et al., 2002). VEGFR2/Flk-1 is expressed in neural retina during mouse 
embryogenesis and has been reported that VEGF mediates mouse RPCs proliferation 
in vitro through VEGFR (Yang and Cepko, 1996). As low O2 activates key signal 
pathway in vivo during early development, our results indicate that lowering O2 
tension during in vitro differentiation may have activated key signaling pathways 
required for CNS development. 
Increasing the efficiency of RPC generation from human pluripotent stem 
cells has a significant advantage for the therapeutic application of stem cell therapy 
for genetic ocular disorders. It has been reported that RPCs generated from human 
pluripotent stem cells are common progenitor cells for Crx and Nrl expressing cells 
that are capable of forming functional photoreceptors upon transplantation (McLaren 
et al., 2006; Lamba et al., 2009; Lamba et al., 2010) However, the efficiency of 
producing these cells is very low and has not been optimized which hinders clinical 
application for treating blindness (Lamba et al., 2010). Our results demonstrate that 
lowering O2 tension enhanced the generation of RPCs which can be used as a source 
material to produce larger numbers of clinically viable post-mitotic precursors. 
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Unfortunately staining for transcription factors such as Pax6 and Chx10 requires a 
permeabilisation step which kills all of the cells. Therefore it is currently not possible 
to sort and reculture Pax6/Chx10 co-expressing RPCs in order to generate a higher 
number of photoreceptors. 
Low O2 can be used in synergy with DKK-1, Noggin and IGF-1 to enhance 
RPCs production 21 days after plating EBs. However, our results suggested that a 
prolonged culture may be required in order to generate post-mitotic or mature 
photoreceptors. We have observed differentiation of ganglion and horizontal cells at 
the same time point in both conditions but failed to detect photoreceptors (Fig 5.12). 
Despite this, we demonstrated how lowered O2 could favour development of 
photoreceptors as a small population of Crx/IRBP expressing cells at 2% O2 which 
was absent in 20% O2 culture (Fig 5.12). It would be interesting to test whether the 
formation of these cells from RPCs using soluble factors such as RA and taurine 
(Osakada et al., 2008) can be enhanced by lowering O2 tension.  
 
5.9 Conclusion 
In this chapter, it was revealed that differentiating human pluripotent cells 
under the atmospheric O2 tension is a suboptimal condition for RPCs formation and 
that the differentiation can be enhanced by lowering the O2 tension near to the 
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physiological level. The neural inducing protocol used in this particular system 
appears to act synergistically with the hypoxic regime employed to induce a 
significant increase in RPCs differentiation efficiency. Working under hypoxic 
conditions increased retinal differentiation efficiency for iPSCs and hESCs, thus the 
effect appears to be generic. This suggests that, in addition to the identified factors, 
microenvironmetal O2 also plays a pivotal role in generating RPCs from pluripotent 
stem cells. 
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6. Concluding remarks and future work 
6.1. Summary of result chapters 
 In this study, the followings were investigated; i) characterization of human 
pluripotent stem cell lines, ii) validate a previously reported RPC differentiation 
protocol using two human pluripotent stem cell lines and iii) the effect of lowering 
O2 tension on the generation of RPCs.  
In chapter 3, we characterized human iPSCs and hESCs. We revealed that 
cells of both cell lines remained undifferentiated during in vitro culture that 
differentiated into cells representing all three embryonic germ layers when cultured 
in suspension (see chapter 3). Confirmation of pluripotency is a critical check point 
prior to generating specific cell types from human pluripotent stem cells. As 
mentioned in Section 3.2.1, we identified some colonies in the culture that failed to 
reprogrammed into iPSCs (Fig 3.1A). In order to examine whether these colonies 
have similar differentiation potentials as fully reprogrammed colonies, Type I and II 
colonies wereselected and subjected to the same retinal differentiation protocol (Fig 
6.1A). The analysis revealed that cells failed to exhibit morphological characteristics 
observed with fully reprogrammed iPSCs and hESCs during adherent retinal 
differentiation (Fig 6.1B) and did not generate RPCs co-expressing Pax6 and Chx10 
(date not shown). This provides supporting evidence of the importance of 
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maintaining pluripotency during in vitro culture.  
 
Figure 6.1. Retinal differentiation of Oct4-negative hES-like colonies from MSUH001-iPSCs culture. 
A) Some colonies exhibiting hESCs-like morphology were Oct4-negative colonies that failed to fully 
reprogrammed. B) These Oct4-negative colonies were selected and directed to differentiate into RPCs 
using the Lamba protocol. The morphological analysis during the differentiation period did not show 
the morphological characteristics observed during iPSCs and hESCs differentiation.   
 
In chapter 4, we investigated whether the Lamba protocol can be repeated 
using MSUH001-iPS and Shef3-hES cell lines with a comparable efficiency. It was 
evident that both cell lines differentiated into RPCs co-expressing RPC markers Pax6 
and Chx10 but with a varying efficiency. In addition, we discovered that MSUH001-
iPS cell line is much favorable in differentiating into RPCs compared to Shef3-hES 
cell line. 
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 In chapter 5, we examined whether RPC generation could be optimized by 
lowering O2 tension during differentiation period. Previous chapter revealed that the 
percentage of RPCs generated from both cell lines was lower than that reported in a 
previous study. To enhance RPC differentiation efficiency, we identified O2 tension 
as a key variable to achieve the goal and results from the previous chapter were used 
as control data to quantify any benefits of manipulating O2 tension. It was revealed 
that lowering O2 tension during differentiation significantly enhance the percentage 
of RPCs co-expressing Pax6 and Chx10 from both cell lines compared to 20% O2. 
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6.2. Conclusion 
 This study has provided promising findings that mimicking physiological O2 
tension enhances generation of RPCs from human pluripotent stem cells. This 
represents another evidence of a growing trend in stem cell biology that maintaining 
O2 at levels found in the developing body is advantageous in differentiating stem 
cells into specific cell types in the body. The implication of the results is that O2 
tension could be manipulated to increase the production of RPCs from human 
pluripotent stem cells that could be used to generate clinically viable retinal cells. As 
mentioned earlier in the chapter, RPCs are capable of generating retinal neurons 
including photoreceptors, therefore producing larger quantities of RPCs using 
lowered O2 tension could subsequently increase the number of photoreceptors for 
possible transplantation.  
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6.3. Challenges associated with the research 
 The biggest challenge for this the research was a “run-to-run” variation of 
RPC differentiation efficiency. The yield varied from ~10% to as much as ~40% cells 
co-expressing Pax6 and Chx10 (Fig 6.2). Despite the varying efficiency of RPC 
differentiation, the effect of lowering O2 was consistent throughout the repeat runs 
although the margin was different. It is difficult to pin-point the cause of the 
efficiency variation however, it was observed that cells differentiate morphologically 
differently depending on the size and shape of EBs (date not shown). This view is in 
line with a previously reported study which examined preferential differentiation 
potential of EBs with varying sizes (Bauwens et al., 2008). Current method used to 
form EBs involves scraping human pluripotent stem cells colonies which results in 
morphologically heterogeneous population of EBs. Production of a morphologically 
uniform and homogenous population of EBs is currently being investigated in our lab 
and it would be interesting to observe whether the optimum size of EBs for 
efficiently generation of RPCs could be determined.  
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Figure 6.2 
 
Figure 6.2. Variation of RPC differentiation efficiency over 8 independent runs. The percentage of 
Pax6 and Chx10 positive cells was inconsistent each time but the effect 2% O2 tension exerted is 
consistent in that it increased the generation of RPCs. 
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6.4. Future works 
6.4.1. The effect of lowered O2 on the generation of transplantable 
retinal cells 
It has been well documented in previous studies that RPCs generated from 
either iPSCs or hESCs have the capabilities to further differentiate into photoreceptor 
precursor cells (Osakada et al., 2008; Lamba et al., 2010). These post-mitotic cells 
expressing Nrl, Crx or IRBP have the ability to migrate to the ONL of retina when 
transplanted subretinally, and develop into mature and functional photoreceptors 
(McLaren et al., 2006; Lamba et al., 2010). For future work, it would be interesting 
to observe whether RPCs derived from MSUH001-iPSCs and Shef3-hESCs could 
also follow the same suit. In order to achieve this, iPSCs and hESCs were induced to 
differentiate into RPCs in the presence of DKK-1, Noggin, IGF-1 and bFGF up to 14 
days after plating EBs. Thereafter, growth factors were withdrawn and factors that 
are known to induce photoreceptor development such as Taurine and RA were 
supplemented to the same basal media (Fig. 6.3A). After a several attempts, the 
preliminary results suggested that possibly supplementing bFGF had exerted 
detrimental effects on the differentiation of RPCs (Fig. 6.3B). When iPSCs-RPCs 
were induced to differentiate in the absence of bFGF, small clusters of cells 
expressed Crx marker (Fig 6.3 B, third attempt and C). In the future, this can be 
taken further to optimize photoreceptor precursor differentiation for a greater yield of 
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transplantable Crx+ cells. This is particularly important as purifying these cells are 
now possible with newly discovered surface antibodies for photoreceptor precursor 
cells (Koso et al., 2009; Lakowski et al., 2011). Optimisation strategies for future 
study may include i) identifying the exact combination of factors and their 
concentration, ii) exploring the use of different extracellular matrices and iii) using 
lowered O2 tension. The use of lowered O2 tension has been preliminarily test by 
placing the differentiation culture under 2% O2 when Taurine and RA were added 
after withdrawing DKK-1, Noggin, IGF-1 and bFGF. This however, resulted in cell 
death, demonstrating the timing of 2% O2 tension switch is equally important and 
required further investigation (Fig 6.3D).   
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Figure 6.3 
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Figure 6.3. Differentiation of photoreceptor precursors from iPSCs- and hESCs- RPC. (A) A 
schematic of differentiation protocol. The eye field factors (DKK-1, Noggin and IGF-1) are removed 
14 days post plating EBs and RA and taurine were supplemented. (B) Different attempts made to 
generate Crx+ cells by using various concentrations of factors that are known to induce photoreceptor 
development (Taurine, DAPT, RA). (C) Clusters of cells expressing Crx marker after 3rd attempt. (D) 
Apoptotic cells 2 days after switching the media under 2% O₂. Scale bar: 100μm. 
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